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ABSTRACT
Clinical practice guidelines (CPGs) are viewed by many people with interests in health
care as valuable tools for reducing practice variations that undermine patient outcomes and
increase medical costs. However, guidelines themselves vary in quality. Assessment tools
generally base quality measures on strength of guidelines’ evidence base, but particularly for
newly emerging applications of ultrasound, standards for measuring guideline quality are
controversial. The validity of a guideline is considered likely when strong research-based
evidence supports its recommendations, but for newer medical procedures such as emerging
ultrasound applications, available evidence is sparse. Existing assessment tools must be
modified if they are effectively to measure the validity of these guidelines built on immature
evidence.
Focusing on ways document drafting affects CPG validity, this study rated six guidelines
using the Appraisal of Guidelines Research and Evaluation (AGREE) tool which was customized
according to categories of guideline purposes and their differing features of validity. Fine-tuning
AGREE in this way may create a more consistent, informative method of evaluating guidelines
for emerging applications, and standards established in such an instrument may be useful as a
template during the guideline development process.
Results from my analyses illuminate several common omissions that weakened
documents. Most guidelines did not describe an updating procedure or identify areas for future
research, but results also highlighted some highly effective techniques for building validity.
Notable examples include providing full credentials for expert drafters, and embedding statement
references directly in the text. From the results of the analysis, I conclude that, although the
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adapted assessment tool I used needs additional adjustment, it may refine analysis of guidelines
for emerging ultrasound guidelines and conversely serve as a useful tool during their
development process.
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CHAPTER ONE: INTRODUCTION
During the last several years the practice of medicine has come under intense scrutiny,
both from external entities and from within the medical community itself. While the rapidly
advancing science of medicine has produced tremendous diagnostic and therapeutic tools, the
cost of medical care has spiraled out of control, with no end in sight. Moreover, patient safety at
the hands of medical caregivers has been called into question. Concerns about these two issues –
patient safety and medical costs – have precipitated a major reappraisal of the medical system
and delivery of health care in the United States.
How can we provide care that is better and more cost-effective? Fundamental to this
question is the problem of unwarranted practice variation leading to inconsistent care and a
spectrum of practices for any given application ranging from best, most effective to ineffective
and even dangerous. Basing care decisions on “best practices” as defined in clinical practice
guidelines (CPGs) is viewed by many as a solution, but for some applications there are multiple
and differing guidelines, and for some emerging applications there are as yet no guidelines at all
(Carter 1649).
My thesis examines clinical practice guidelines, with particular focus on how
construction of guideline documents affects overall guideline quality. To establish context for
discussing written communication issues, I explore the role of CPGs in promoting best clinical
practices, how the quality of existing guidelines can be assessed, and how future guidelines
might be developed and constructed to reduce unwarranted practice variation and exert
maximum positive impact on patient outcomes and cost of care. My thesis examines the role of
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guidelines in promoting best clinical practices, how the quality of existing guidelines can be
assessed, and how future guidelines might be developed and constructed to reduce unwarranted
practice variation and exert maximum positive impact on patient outcomes and cost of care. In
the sections that follow I describe the patient safety and cost issues associated with practice
variation, and I discuss how those problems precipitated a proliferation of CPGs. I define the
distinguishing characteristics of these documents and examine methods of assessing CPG quality.
Finally, I explore special demands associated with developing guidelines for emerging
applications. This background information will lay a foundation for construction of a guideline
development template the American Institute of Ultrasound in Medicine, along with its
collaborative partners, can use to produce useful, high quality guidelines for emerging
applications.
I propose that three major challenges are likely to present themselves for developers of
emerging applications guidelines. First, there is the question of whether, as opponents will
charge, it is even appropriate to devise guidelines for narrow exams to be performed by
clinicians who are not ultrasound specialists. And indeed the question of appropriateness should
be addressed in such a guideline. The second challenge will be overcoming potential
philosophical discord among a diverse group of practitioners practicing in a variety of settings
with a variety of skill sets. Third, for novel applications, there will be very little evidence on
which to base guideline recommendations. Each of these theoretical issues presents challenges
for content experts and for technical communicators drafting the documents.
In my thesis I propose to discuss these guideline needs of emerging ultrasound users’
groups, and to explore ways the document drafters can contribute to the development of sound
guidelines for this diverse group. These are my key questions:
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1) How should guidelines for emerging ultrasound applications be assessed?
2) Is it appropriate to develop guidelines for these applications?
3) If so, how can these guidelines best be constructed for validity and usability?

Quest for Effective Medical Care
The history of medicine recounts the eternal human quest for ways to combat disease and
promote health and well-being. But disease processes are complex, and the quest for most
effective, or “best,” diagnostic and treatment approaches has led medical investigators down
myriad fruitless, even bizarre, pathways. Consider the practice of medicine in colonial America.
Colony “doctors,” most of whom were educated entirely through apprenticeships, attacked their
patients’ ails with copious blood-letting and all manner of strange and vile concoctions. In the
1600s, “best practice” in the treatment of apparent blood diseases meant a prescription for
tincture of charred toad. For madness there was St John’s wort, and for itching, patients were
prescribed a brandy-turpentine-hog’s fat-fish worm cocktail. From what may have been the only
medical text book available in the Colonies, its author, Dr. Frances Packard, advised “For paines
in ye Brest or Limmes; Weare a Wilde Catts skin on ye place grieved” (20).
One might suspect that patients’ safety in early America was threatened by proximity to
the very treatments doctors regarded as “best practices.” In fact, some historians suggest that
during the 1793 Yellow Fever epidemic, more people died from medical “care” than from the
disease itself.
For the first century of America’s history, colonial physicians had little more than lore
and superstition on which to base their patient care decisions. “Evidence-based medicine” as we
define it today was essentially nonexistent in those early years of American medicine. But in
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1765 the quest to unravel the mysteries of disease sprouted academic roots with the opening of
North America’s first medical school at the College of Philadelphia, now the University of
Pennsylvania. King’s College, predecessor to Columbia University, quickly followed suit,
conferring its first medical degree in 1770. In 1823 the University of Maryland built the first US
teaching hospital, providing the fledgling American medical community with a formal research
home where investigators could examine theories and grow evidence. Evidence of most
effective practices presumably provides clinicians with clear answers to how to best care for
patients.

Practice Variation and Patient Outcomes
Unique insights are essential to the art of medicine. In fact, some of medicine’s most
important advances have proceeded from individual flashes of intuition, only later supported by
scientific evidence. An example is the germ theory of disease. In 1847, well before the germ
theory was confirmed, Hungarian physician Ignac Semmelweis noted the much lower rate of
“childbed fever” among women delivered by midwives, rather than by physicians who attended
them with unwashed hands, immediately after performing autopsies. Based on his clinical
observations and intuitive conclusions, Semmelweis established a “guideline” requiring
physicians to wash their hands before deliveries, and in so doing, greatly reduced maternal
morbidity and mortality. It was not until 1890 when the germ theory of disease was finally
scientifically confirmed by Robert Koch.
For the 19th and most of the 20th century, the practice of medicine relied more heavily on
the common sense and powers of observation of the care giver than on formal evidence and
broadly endorsed practice guidelines. Some of us still remember the family doctors of the 1950s

4

and 60s. Equipped with their black bags, physicians with their arcane knowledge were trusted by
their patients as much for their sage judgment as for their medical educations. In fact, from
formal education doctors learned about treatment options, but it was from their experiences that
they built what were very personal “evidence bases” on which to found care decisions. The
doctor who saw one patient improve while following a particular regimen might generalize and
apply that technique to all patients with the same complaint; a colleague in another community,
informed by different experiences, might perceive “best” patient outcomes in response to another
regimen. The practice of medicine varied among physicians according to their individual
experiences and interpretations.
Such variations in the practice of medicine seem charmingly Norman Rockwell, but, in
fact, these disparities are associated with inconsistent, often poor, quality of care. According to
Charlton, even with access to 21st century medicine, some clinicians “persist in old-fashioned
and eccentric practices under the guise of ‘clinical freedom’” (Charlton 99-101). Many other
complex factors are associated with inconsistent care as well. Geographic variations have been
reported, particularly with respect to prescription of drugs, and disparities in care have been
reported associated with numerous social factors, including patients’ ethnicity, health provider,
economic status, and gender. Schuster et al reviewed 48 articles that assessed the quality of
preventive, acute, and chronic health care services in the United States. From their review these
investigators concluded that among all populations “there are large gaps between the care people
should receive and the care they do receive” (Schuster 517-563).
Clearly “wrong,” or “inappropriate” care harms patients as occurs in the “wrong
site/wrong procedure/wrong patient” scenario. “Too much” care in the form of unnecessary
medications and services is also injurious, increasing the patient’s risks and side effects. A rising
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number of unnecessary caesarean sections is increasing both maternal risk from surgical
complications and fetal risk from sometimes-preterm delivery is an example of too much care.
As conventional wisdom would predict, increased morbidity and mortality result from
“too little” care, as when potentially beneficial diagnostic or therapeutic services are not offered.
According to a Dartmouth Atlas Project Topic Brief on effective care, more than 68,000 people
die each year from causes related to hypertension, but fewer than 65% of hypertensive patients
receive recommended care. Fewer than two thirds of older Americans receive the pneumonia
vaccine, resulting in nearly 100,000 preventable deaths each year. According to the Dartmouth
report, “effective care is underused largely because our health care system lacks the means of
supporting systematic compliance with treatment guidelines” (Dartmouth ).
Nearly two centuries after the birth of medical education in the US, we shake our heads
and smile at the 18th century colonial doctor’s leeches and poisons. But even with our more
sophisticated knowledge, pharmacologies, and technologies, the practice of medicine remains
imperfect. Clinicians still seek answers to questions as to how to provide best care for their
patients, and patients still suffer at the hands of medical care givers. In fact, in 1991 the New
England Journal of Medicine reported that, according to statistics gathered by a Harvard Medical
Practice Study, an estimated 33,000-98,000 people die each year as a result of medical errors
(10). That disturbing report catalyzed a widesweeping movement in the medical community to
search out root causes for errors, to find ways to safeguard patients, and to optimize delivery of
patient care. CPGs have been cited as key to more consistent care and better patient outcomes.
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Rising Medical Costs
Reducing unwarranted practice variation is driving a strong movement towards CPGs as
tools for promoting patient welfare; another factor driving the guidelines movement is their
hoped-for potential to improve the medical cost/benefit ratio and help contain the unsustainable
rate of increase in health care costs. From $294.3 billion in 1969, in 2009 the cost of health care
skyrocketed to $2.5 trillion, and higher spending levels are not associated with improved
outcomes (Woolhandler 768). The Commonwealth Fund annually compares healthcare costs and
outcomes of several countries. In its 2007 report, among Australia, Canada, France, Germany,
Japan, Norway, Sweden, the United Kingdom, and the United States, in the US per capita health
care costs at nearly 17 percent of the gross domestic product (GDP) were the highest while life
expectancy and infant mortality were the worst. By reducing practice variation, can CPGs lead
to better patient outcomes and more efficient use of medical resources?

History of CPGs
Guidelines have been used in medicine for centuries. Perhaps the earliest example in
Western literature is the medical ethics guideline ascribed to Hippocrates. Thought to have been
written around 400 BC, the “Hippocratic Oath” defined an ideal “Do no harm” practitionerpatient relationship still relevant today.
The modern guidelines movement began more than 50 years ago, and surged late in the
20th century as concern grew regarding the rising cost of health care. According to Farmer, the
rate of healthcare spending began accelerating in the 1960s when Medicaid/Medicare began
offering extremely low cost care to poor and senior citizens. HMOs were created to try to regain
control, but these managed care organizations failed to effectively slow spending.
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Answers to the growing crisis were sought in outcomes research, and in 1987 William
Roper, Chief of the Health Care Financing Administration (HCFA) launched a series of seminars
focused on improving health care. One conclusion from Roper’s initiative was reported by
researcher John Wennberg who demonstrated variations in healthcare, and healthcare costs,
stemming from the way doctors were doing business. Also as a result of the initiative, Robert
Brook of the Rand Corporation developed criteria for judging appropriate performance of
medical procedures. In 1988 Roper’s effectiveness initiative was formalized by HCFA, and the
National Institutes of Health (NIH) and the National Center for Health Services Research
(NCHSR) joined as partners to continue the outcomes research.
It was in 1989 that guidelines became a real national focus. That year Congress charged
the NCHSR, eventually renamed the Agency for Healthcare Research and Quality (AHRQ), with
leading in the task of developing and evaluating CPGs. Interest in evidence-based guidelines was
evolving, and in 1989 the Institute of Medicine (IOM) launched an initiative to evaluate the
quality of CPGs and plan ways to advance the art of guideline development. CPGs were
formalized as a genre in 1990 when the IOM formally defined them as “systematically developed
statements to assist practitioners and patients in choosing appropriate health care for specific
clinical conditions” (Field 38).

The Role of CPGs in Reducing Practice Variation
According to a report from the Agency for Healthcare Research and Quality (AHRQ), a
research arm of the US Department of Health and Human Services, “Scientific studies have
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proven that following best practice guidelines reduces suffering and patient mortality, while
improving quality of life and clinical outcomes” (??).
Guyatt et al acknowledge that practice should be guided by findings reported in the
literature, but they maintain that for many practitioners the medical literature is inaccessible.
“Researchers studying the literature must accurately interpret a diverse range of journal articles
and analyze the overall statistical findings, as well as the circumstances unique to each included
study” (from AHRP website http://www.ahrq.gov/clinic/epc/qgapfact.htm).
Compounding the difficulty for individuals attempting to stay abreast of the literature, its
volume is staggering, and increasing. According to Guyatt, “every few years the literature
doubles in size, and every year we seem to have less time to weigh it,1” (Guyatt or Durack –
check this reference - ) Especially as technological innovation explodes and research into
application outcomes flourishes, it becomes increasingly difficult for clinicians to review all
available literature on a topic.
As long ago as 1951 Garland identified the problem for radiologists: “The expanding
literature on radiology threatens to engulf the serious worker. Since radiology embraces the
diagnostic and therapeutic applications of radiant energy in the entire field of medicine, this
expansion is both understandable and inevitable” (??).
Garland’s 1951 predictions were correct. In fact, American diagnostic radiology
researchers published 468 papers in 1960 and nearly 3000 in 1984 (Chew 1055); between 1990
and 2005 more than 7500 original articles were published in the journal of the Radiological
Society of North America alone (Arrive 330). Rapidly accumulating medical research data is,
indeed, expanding the literature to such a volume that clinicians can no longer rely on personal
reading to keep them abreast of all research findings relevant to their areas of practice. To further
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complicate the clinician’s task of digesting the literature, conclusions of different studies often
conflict.”
One broadly supported solution to the problems with the literature (2 Goolsby) is to look
to teams of experts to review all possible care options, weigh the evidence for and against each,
and, based on the evidence, develop evidence-based care recommendations communicated
through clinical practice guidelines (CPGs), Battista 7: “CPGs offer the potential to reduce
uncertainty attributable to suboptimal decision-making due to unfamiliarity with relevant
scientific knowledge” (provide source info at end of passage).
Across the board, the health care industry is focused on standards and guidelines as tools
for promoting patient welfare. For example, some commercial health plan programs, or “3rd party
payers,” have instituted strict quality measures of “privileging” and “site accreditation” as
conditions for reimbursement for imaging services. DC Levin and VM Rao describe Blue Cross
Blue Shield programs, and they report how those quality requirements have affected the delivery
of health care. According to these authors, by reimbursing for only those services provided by
practitioners with specific training, third party payers have helped reduce the number of studies
completed by low-quality providers; by requiring site accreditation as a condition for payment,
these commercial health plan providers are raising the bar on facility quality standards.
At issue: do CPGs work? How do guideline developers write these documents to be
effective? And how can potential users assess the likeliness of reliability of recommendations?

Introduction to Ultrasound Guidelines and Emerging Applications
In ultrasound, as in other areas of medicine, practice guidelines are developed and
regularly revised to articulate the community’s agreed-upon minimum standards of care.
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Currently the American Institute of Ultrasound in Medicine (AIUM) publishes 24 practice
guidelines developed by its Clinical Standards Committee (CSC), most guidelines in
collaboration with one or more other professional organizations. Writing and revising guidelines
even for fairly standard practices is complicated and strongly rhetorical. Guidelines must be
carefully worded to protect patients, protect doctors and other caregivers, satisfy regulating
agencies like the Joint Commission, and satisfy third party payers. Complex collective voice,
complex audience, complex purpose—these and other elements add up to complex content
development and technical communication challenges.
While many medical guidelines address specific disorders, most current ultrasound
guidelines outline performance and training standards for imaging a particular body structure, or
group of structures. Traditionally, ultrasound examinations are performed in designated
ultrasound laboratories by ultrasound imaging specialists. Outpatients travel to these facilities,
and patients already receiving care in a facility are moved to the ultrasound lab for the exam. But
the practice of ultrasound is changing; traditional body part imaging is no longer the only
application for this very user-friendly technology, and the ultrasound department with its
specialized clinicians is no longer its only setting. Because ultrasound is free of ionizing
radiation, highly portable, and relatively inexpensive, medical caregivers from specialties outside
traditional imaging boundaries are picking up transducers and trying them out for an expanding
array of new uses, many at the “point of care” in labor and intensive care units, emergency
departments, and surgical suites. Emergency physicians examining critically injured patients are
using ultrasound for a quick look for internal bleeding; nurses are using it to guide insertion of
PICC lines; anesthesiologists are looking with ultrasound to localize a nerve for injection. And
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that short list covers only a few of the possible new uses. Traditional imaging ultrasound is being
joined by an explosion of emerging applications.
The characteristic that distinguishes an application as “emerging” generally falls into one
of these categories: use of ultrasound to examine structures not traditionally evaluated with
ultrasound; or use of the technology to perform traditional imaging tasks in nontraditional
settings, by practitioners whose primary specialty is not ultrasound imaging, or with a more
limited scope. Some characteristics of these emerging applications are controversial and may
pose challenges to achieving consensual guidelines. Of the features that characterize emerging
applications, the two that may prove most contentious relate to exam scope and practitioner
provider. To protect patients from inconsistent, insufficient care, the standards of the traditional
sonography community require performance of "complete" examinations, and only by
credentialed sonographers or physicians as described by existing CPGs. Any guideline verbiage
that is perceived to dilute these standards will likely meet with strong opposition.
Two major factors are driving interest in development of guidelines for emerging users of
ultrasound. First, the number of new users is large and growing, and both users and patients
would likely benefit from guidelines outlining the safest, most effective techniques for their new
applications. Second, the current medical climate and the huge push for improved patient safety
is promoting guidelines and standards as a means to reduce errors and improve effectiveness of
medical care decisions. Exploring the task of developing practice guidelines for emerging users
of ultrasound is timely and important both for practitioners and for their patients.
In Chapter Two, I review the literature review that describes the format and attributes that
characterize clinical practice guidelines. I explore the challenges inherent in writing high quality
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guidelines with a focus on the special challenges associated with emerging point-of-care
ultrasound applications.
In Chapter Three, “Methodology,” I discuss the Appraisal of Guidelines Research in
Evaluation (AGREE) instrument as a tool for assessing writing practices that affect the validity
and usability of a docment. AGREE is a validated and well accepted tool, but it is not entirely
appropriate for assessing guidelines for emerging ultrasound applications or for other guidelines
of similar purpose. Adjusting AGREE according to needs I assigned to emerging users’
guidelines, I developed an assessment tool to use for these documents.
In Chapter Four I present my analyses of six clinical practice guidelines that address
various ultrasound applications. Using the rubric developed through the process described in
Chapter Three, I assess text components of these documents and rate how effectively each one
promotes guideline validity and usability. Although I assign a score to attributes and to each
document overall, the primary purpose of my assessments is to identify writing practices that
weaken guidelines and to highlight practices that make the documents strong. With this study I
evaluate features and writing challenges fundamental to CPGs, but I direct special focus toward
those attributes that may prove most important, and most challenging, for developers of
guidelines for emerging ultrasound applications.
In Chapter Five, I describe conclusions based on the literature and on my experiment
with guideline document assessment. Applying the conclusions I reached with respect to
assessments, I developed a template for drafting emerging users’ guidelines. Finally, combining
the assessment tool described in Chapter Three with the template descried in Chapter Five, I
provide a CPG Quality Assessment and Construction Toolkit (Appendix B). I believe findings
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and conclusions from this thesis may be used by guideline drafters to enhance the quality of
CPGs for emerging users.

14

CHAPTER TWO: LITERATURE REVIEW
The rapid increase in the number of CPGs published during the past several years gives
testament to people’s belief in their potential to reduce practice variation. But guideline
development as a discipline is scrutinizing itself. In their seminal 1993 article, Grimshaw and
Russell state that “the quality of published guidelines is variable” (Developing 243). As a result
of this concern, there is growing interest in ways to assess guidelines and to apply quality
measures prospectively during the development process. In this literature review, I discuss the
basic format and attributes that characterize CPGs, and I explore the demands inherent in writing
high quality guidelines, with a focus on the special challenges associated with emerging point-ofcare ultrasound applications.
Many CPG development groups have looked at ways to evaluate guideline quality. Some
groups focus on topics related to gathering and grading evidence; others examine the method
used to formulate recommendations; still others discuss strategies for implementation. I reviewed
those topics, but with a focus on the role of the writer in effectively conveying the nature of
those processes and findings. Next, I reviewed the literature that differentiates guidelines
according to their purposes, and examined how their different functions might affect document
characteristics. I gave special consideration to the guideline needs for emerging ultrasound
applications.
Using University of Central Florida online library resources, I first sought relevant
sources through a Medline search using these key words and key word phrases: clinical practice
guidelines, practice guidelines, medical guidelines, guidelines, performance guidelines, history
of guidelines, validity, collaboration, collaborative techniques. Using the same key words and
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phrases, I searched the Internet using Google and Google Scholar. Some additional sources were
identified from among bibliographic references in selected articles, and others were
recommended by a physician colleague. To identify primary guideline documents for analysis, I
searched the Internet using key words “medical professional organizations,” and then selected
and downloaded CPGs from organizations’ websites. An e-mail from a patient is included with
her permission.

The Rhetorical Challenge
Compelling considerations underlie the writing challenges inherent in this specialized
genre of medical literature, and recommendations conveyed by guidelines bear significant
clinical, professional, and economic impact. Health outcomes are most important, but the cost of
suggested care must be taken into account when advocating care practices, as well as the
obligations guideline recommendations impose upon clinician’s resources. In a way, CPGs
represent a negotiated understanding between all members of the audience, and the audiences for
these highly consequential documents are multiple and complex. As an example, the primary
audience for an obstetrical ultrasound guideline includes sonographers and sonologists who
perform the exam according to the guideline-recommended protocol. Then to this alreadydiverse group, with its range of background experiences, add the physicians, physician assistants,
and midwives who refer patients for ultrasounds based on indications listed in guidelines, and the
more distant but still real audience of patients, insurers, legislators, and others.
Each of these reader groups views CPGs through a lens of special interest. For example,
according to Grimshaw, the costs of recommended care may be of particular concern to third
party payers. In fact, for major purchasers of health care, like the Centers for Medicare and
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Medicaid Services (CMS), cost effectiveness is a critical issue. With the cost of medical care
rising at a rate that exceeds inflation and the gross domestic product, these CPG purchasers will
likely examine guidelines for evidence of clinical and cost effectiveness of recommended care.
Across the board the health care industry is focused on standards and guidelines as tools
for promoting patient welfare. For example, some commercial health plan programs, or “third
party payers,” only reimburse for imaging services performed by providers who are identified
through accreditation programs of professional organizations like the American Institute of
Ultrasound in Medicine (AIUM) as adhering to high standards of patient care. Since to be
designated as “accredited,” clinical groups must agree to practice according to specific
guidelines, CPG preferences of these large insurers bear significant implications for health care
providers.
There is evidence of positive outcomes from insurers’ support of guideline-based
practices. Levin and Rao describe Blue Cross Blue Shield programs, reporting how their quality
requirements have affected the delivery of health care. According to these authors, by
reimbursing for only those services delivered by practitioners with specific training, third party
payers have helped reduce the number of studies completed by low-quality providers (535). By
requiring site accreditation and adherence to particular guidelines as a condition for payment,
these commercial health plan providers are raising the bar on facility quality standards. And
movement toward accreditation and encouraging practice according to guidelines as a condition
for compensation will continue. United Healthcare (UHC), one of the largest private insurance
companies in the US, declares on its website that it now reimburses only accredited providers for
performance of Computed Tomography, Magnetic Resonance Imaging, and Positron Emission
Tomography, and some cardiology imaging procedures, and they are considering “future
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application to other ultrasound services.” UHC’s website reports that by January 1, 2012,
Medicare will also require provider accreditation as a condition for payment of some imaging
fees.
Clinicians, insurers, and legislators have interests in reading CPGs, and some patients are
reading medical literature, including practice guidelines, as well. Just a few years ago Americans
regarded the principles of medicine as mysterious, largely inscrutable concepts; physicians with
their secret knowledge were revered and rarely questioned. But today, thanks to the World Wide
Web, a staggering volume of medical information (and misinformation) is readily available to
anyone with access to the internet. Any lay person can google “H1N1” and reach roughly
132,000,000 relevant sites. The Internet surfer in a small town in Alaska need only type in
keyword “headache” to learn about headache symptoms, diagnosis, and treatment from some
26,700,000 sites.
The cyber-information explosion is making lay diagnosticians of us all, and contributing
to a paradigm shift in the clinician-patient relationship. For as Frederick Douglass learned,
information access is empowering. In his autobiography, Douglass relates his master’s
opposition to his wife’s teaching the young slave to read: “If you teach [Douglass] how to read,
there would be no keeping him. It would forever unfit him to be a slave… . It would make him
discontented and unhappy” (1071). As Douglass discovered, his master was right: information
access leads to questioning.
Indeed, today’s more informed patients are much more likely than their grandparents to
question their care providers, and 21st century patients’ outcomes expectations are greater.
Americans witnessing the medical innovations and improved outcomes of the last few years have
come to expect a lot from their medical care and care providers. In the following e-mail, a patient
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recounts her family’s difficult experience at the birth of her child, and conveys her frustration
with failure of prenatal ultrasound clinicians to identify her baby’s serious structural defect. The
patient specifically references prenatal ultrasound guideline recommendations that were not
followed during her exam.
2/26/2010
My son was born in December 2007 with Bladder Exstrophy. This condition went
undetected prenatally by ultrasound. I am a nurse and have studied my son's ultrasounds
(5 total), radiology reports, and fetal anatomy criteria to be met by ultrasound.
…
Our radiology report does not document umbilical cord insertion site, the route of the
arteries to the umbilical cord, a definitive abdominal wall, emptying and filling of the
bladder, or pelvic bone structure. The radiologist did document that the bladder could not
be seen but later amended the report saying that the structure must be very small.
Our obstetrician never questioned these reports nor mentioned any concerns to me or my
husband.
The only change to the outcome of our situation would have been preparation for birth,
preparation financially, and the ability to shield our then 8 year old daughter from a
frightening situation. Our son was born vaginally, in a rural hospital to staff who had
never seen this condition, ill equipped to care for our baby. He was transported to
Jacksonville, where we were questioned on several occasions as to why we did not
receive prenatal care.
That day quickly turned from one of the most joyous days of my life to a nightmare. God
has blessed us, and our son is doing great. He will have future surgeries and has endured
four to date. My fear is that others will be faced with a similar situation, when it can be
prevented.
Parents should have the opportunity to arrange for their birth to take place in a facility
equipped to handle this type of case and the proper birthing method. They should have
the opportunity to prepare themselves financially for this situation. We have incurred
medical costs that we will not soon overcome. They should have the opportunity to learn
about this birth defect and know what to expect after birth. This condition requires a
progressive approach, babies will endure several surgeries, parents need to be trained in
what they can do to help their child heal. They should have the opportunity to prepare
their families, other siblings and grandparents, it is devastating to not know why no one
can see or hold the long awaited bundle of joy.
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My goal is to raise awareness in the medical community and the need for continuing
education to keep technicians, radiologists and obstetricians current and informed in
medical advances along with proper diagnosis given specific tests outcomes.
Clearly audiences for guidelines include a wide range of readers, from specialized
clinicians to patients with no medical background, and these readers are often strongly vested in
their perceptions of the recommendations and outcomes described in CPGs. To meet the
rhetorical responsibilities imposed by these factors, developers of all types of clinical practice
guidelines are charged with wording information accurately and in such a way as to be
understood concordantly by all members of the audience This is no simple task, for as Richards
and Ogden note in “The Meaning of Meaning,” “Words… are a very imperfect means of
communication” (1277). Particularly in light of potential ramifications of misinterpretation, it
may not be sufficient for content experts to simply state the facts. As Kenneth Burke observed,
“We can safely take it for granted that no one’s ‘personal equations’ are quite identical with
anyone else’s” (1345).
Such ambiguity as Burke describes challenges interpretation of the most fundamental
descriptor of clinical practice guidelines, the term that is often regarded as synonymous with
high quality: “evidence-based.” McAlister et al observe that this seemingly explicit term may
carry different meanings for guideline developers than for clinicians. To clinicians, ”evidencebased” may seem to imply the high quality of RCTs while for guideline developers the term
strictly means that recommendations are based on evidence that was derived from systematic
search and evaluated as to strength. This important distinction illustrates the difficulty of writing
meaningful, unambiguous, high quality guidelines.
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Guideline Attributes
In drafting these complex documents, technical communicators with their specialized
wordsmithing skills can provide valuable assistance to the content expert members of guideline
development committees. In fact, the overall quality of a guideline depends on both its ideas and
its documentation. Grimshaw and Russell frame the broad concept of guideline development,
intertwining the process of developing content with the task of drafting the final, implementable
document. In the first in their series of articles, the authors identify and define nine fundamental
attributes of CPG quality (Developing Scientifically 245):


Validity



Reproducibility



Reliability



Representative development



Clinical applicability



Clinical flexibility



Clarity



Meticulous documentation



Scheduled review
Of these nine attributes described by Grimshaw, two directly relate to authors’ technical

task of document construction: clarity and meticulous documentation. According to Grimshaw
and Russell, document clarity depends on accurate, unambiguous presentation of information in
a format designed for easy access (Developing Scientifically 245). Meticulous documentation
requires accurate reporting of all details of guideline development.
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Two other attributes relate to the functional application of guideline recommendations:
clinical applicability and clinical flexibility. The authors assert that guidelines have clinical
applicability if the recommendations suit the defined patient population. The attribute of clinical
flexibility provides leeway and guidance for clinical judgment to override recommendations. The
attribute of scheduled review ensures that recommendations are based on current evidence and
will be updated as evidence changes.
Grimshaw and Russell characterize “validity” as a more global attribute than the others,
and of the most critical importance to guideline quality. It is also likely the attribute that will
prove the most challenging for developers of emerging users’ guidelines to implement. So what
does it mean for a guideline to be “valid”? How is that quality defined? According to Dorland’s
Illustrated Medical Dictionary, validity is “the extent to which a measurement, test, or study
measures what it purports to measure” (“Validity,” def. 1). The Agency for Healthcare Research
and Quality (AHRQ) Glossary of Terms located on their website offers a similar definition,
stating that validity is determined by “whether a test or technique actually measures what it is
intended to measure.” The AHRQ applies that general definition with respect to guidelines, tying
validity to expected health and cost outcomes. Similarly, in their 1995 article, Grimshaw et al
specify that the validity of guidelines is measured by their effect on patient outcomes and
resource utilization. They define guidelines as “valid if, when followed, they lead to
improvement in patient outcome at acceptable costs” (Implementing 61).
According to Grimshaw and Russell , the quality of validity depends on AHRQ’a three
remaining attributes of reproducibility, reliability, and representative development. They say that
reproducibility means a guideline’s recommendations should seem appropriate to the evidence
base as interpreted by various groups; reliability assures that groups other than the guideline
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drafters will be likely to apply the guideline similarly and under similar circumstances. The
authors assert that to promote these two conditions of reproducibility and reliability, the
guideline development group must include representatives of all relevant interests.
Grimshaw’s “attributes” inform the task of capturing validity in these documents.
According to the AHRQ, three factors constitute the main influences on guideline validity: 1) the
strength of the evidence on which recommendations are based, 2) the method used to evaluate
the evidence, and 3) the relationship between the force of recommendations and the strength of
the supporting evidence. In the next sections I review the literature related to each of these three
influences, and I discuss the dual and complimentary roles of content experts and technical
communicators in addressing these elements.

Characterizing the Evidence
Various authors discuss factors that affect the quality and strength of evidence. Several
authors stress the importance of a literature review as a basis for evidence quality. Drafters’
meticulous reporting of the literature search and review process enhances the document’s
validity by communicating to users the degree to which they can rely on the guideline’s
recommendations. Through a formal, objective literature review, evidence relevant to a
guideline’s topic is located and considered. Grimshaw advises that guidelines developed
“without a lit review may be biased towards reinforcing current practice rather than promoting
evidence-based practice” (Developing Scientifically 246). In another article Grimshaw warns of
the potential for bias when formal systematic literature reviews are absent from the development
process and recommendations are based entirely on the literature familiar to and supplemented
by the opinions of the committee members. According to Grimshaw, such recommendations
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“often lag behind available evidence and may reflect individual enthusiasms rather than the
knowledge base” (Developing and Implementing 61).
Shekelle et al provide details appropriate to this report item. In the second article of a
series on guideline development, these authors outline an evidence search method, beginning
with the step of consulting an up-to-date systematic review on the guideline topic. In the absence
of an available systematic review, they describe using formal computer search strategies to locate
relevant, appropriately designed studies.
The literature suggests that guideline drafters promote validity by accurately
characterizing the strength of each piece of evidence that comprises a CPG’s evidence base. That
strength of evidence, according to the Training Manual for The AGREE Collaboration Appraisal
of Research and Evaluation (AGREE) Instrument, is related to “the extent to which all aspects of
a study’s design and conduct can be shown to protect against systematic bias, non-systematic
bias, and inferential error” (62).
Guideline drafters transparently report the risk of bias inherent in evidence by properly
characterizing its study design and applicability. According to the ranking scheme of the AHRQ,
evidence least vulnerable to bias is that which is obtained from systematic reviews and metaanalyses of randomized controlled trials. Since these studies include large numbers of
participants, the effects of individual-specific, unintended variables are minimized, and
proceeding results are highly reliable. Also highly reliable, but one step down because of lesser
numbers, are randomized controlled trials. Vulnerability to bias increases for evidence from the
next category of studies, non-randomized intervention studies, and increases even more with
observational and non-experimental studies. The AHRQ ranks expert opinion as the lowest
quality of evidence with the greatest risk of bias. Other guideline developers rank evidence
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quality similarly, generally regarding the strength of evidence as inversely related to the
possibility of study bias and directly related to the quality of the study design and
implementation.
McAlister et al identify clinical relevance as another factor that affects CPG validity.
According to McAlister et al, even guideline recommendations based on “high quality” evidence
from internally valid RCTs are of less than “high” quality if clinically irrelevant or not directly
applicable to the target population. These authors analyzed bibliographies of guidelines for
treatment of type 2 diabetes mellitus. Of 15 “evidence-based” guidelines, there was very little
concordance of reference selection, and the study cited most frequently among the guidelines’
references did not actually include patients with type 2 diabetes mellitus. To define the quality of
their evidence bases more effectively, these authors advocate grading guidelines using schemes
that take into account the clinical relevance and applicability of recommendations (e250).
Drafters’ meticulous reporting of the literature search and review process enhances the
document’s validity by communicating to users the degree to which they can rely on the
guideline’s recommendations. In a description of the process, Shekelle et al provide details
appropriate to this report item. In the second article of a series on guideline development, these
authors outline an evidence search method, beginning with the step of consulting an up-to-date
systematic review on the guideline topic. In the absence of an available systematic review, they
describe using formal computer search strategies to locate relevant, appropriately designed
studies.
The authors describe how selected evidence may be rated, interpreted, and translated into
recommendations of various strengths, depending on the quality of their evidence base.
According to Shekelle et al “Recommendations based solely on clinical judgment and experience
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are likely to be more susceptible to bias and self interest.” When expert opinion is incorporated,
“the process needs to be made as explicit as possible” (Shekelle 595). Recommendation grades
convey with what confidence guideline developers level of confidence that following the
recommendation will lead to the predicted outcome.
Grimshaw and Russell discuss the relationship between the evidence and validity, and
they rate the likelihood of various evidence bases leading to valid guidelines. From formal metaanalyses and graded systematic reviews, they predict “high” likelihood; with ungraded
systematic reviews they predict “medium”; from unsystematic reviews or from expert opinion
they predict “low” likelihood of guideline scientific validity. At issue in terms of bias and
evidence synthesis: expert opinion alone tends to reinforce existing practices. Objective
conclusions depend on unbiased consideration and interpretation of all possible solutions and
outcomes (Developing Scientifically 245).
The tasks of grading the evidence according to its risk for bias, and rating
recommendations according to assigned strength are simplified by many groups by symbolically
encoding the information. Different organizations use varying codes, but as an example,
following is the classification scheme reported by Shekelle et al (595):
Category of evidence
Ia-evidence for meta-analysis of randomised controlled trials
Ib-evidence from at least one randomized controlled trial
IIa-evidence from at least one controlled study without randomissation
IIb-evidence from at least one other type of quasi-experimental study
III-evidence from non-experimental descriptive studies, such as comparative studies,
correlation studies, and case-control studies
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IV-evidence from expert committee reports or opinions or clinical experience of
respected authorities, or both.

Presenting Recommendations
Strength of recommendations
A-directly based on category I evidence
B-directly based on category II evidence or extrapolated recommendation from category I
evidence
C-directly based on category III evidence or exrrapolated recommendation from category
I or II evidence
D-directly based on category IV evidence or extrapolated recommendation from category
I, II or III evidence
Inevitably evidence is viewed through the lens of cultural values, which helps explain
variation in recommendations among different guidelines developed for a single application. For
example, looking at cholesterol management guidelines, Battista et al note differences in the
scopes between those of the United States and Canada. These authors contend that the difference
reflects “a cultural preference for greater caution in Canada” (Uneasy Juncture 878). The
perspective of Battista et al highlights the rhetorical task inherent in writing guidelines. The
authors illuminate the challenge of drafting guidelines that base recommendations on evidence
but stop short of stripping away the art of physician judgment informed by physician-patient
interaction (Between 385).
Ultimately the greatest impact on patient care comes from a guideline’s recommendations,
so the wording of recommendations is arguably the most important part of the drafters’ task, and
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it may be the most difficult. It is certainly the most rhetorical guideline draft task, as the meaning
of recommendations emerges from the person reading it. The CDC identifies 3 audiences for its
guidelines: patients, clinicians, and policymakers, and sets explicit communication goals for
each:
For patients, guideline categories convey desirability of the course of action. Category I
means “Most people in the patient’s situation would want the recommended course of action and
only a small proportion would not.” Category II means “Most people in the patient’s situation
would want the recommended course of action, but some may not” (US CDC 17).
To clinicians, categories convey level of clinical imperative for a course of action:
Category I means “Most patients should receive the recommended course of action.” Category II
means “Different choices will be appropriate for different patients and clinicians must help
patients arrive at management decisions consistent with her or his values and preferences” (US
CDC 17).
For policymakers, categories indicate level of mandate. According to the CDC, Category
I recommendations “may be considered for policy in many situations.” Category II
recommendations will require “substantial debate” to be translated into policy (US CDC 17)
The strength of a recommendation is generally linked to the quality of the evidence, with
high quality evidence leading to strong recommendations. For Category I recommendations,
strongly directive verbs, like “do” or “do not” are used; for Category II recommendations, verbs
like “consider” are used (US CDC 18).
Guideline drafters explicitly select verbs to convey the strength of each recommendation.
Generally, the expressed intent of ultrasound practice guidelines is to provide flexible
guidance. From the preamble to all AIUM practice guidelines:
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Practice guidelines of the AIUM are intended to provide the medical ultrasound
community with guidelines for the performance and recording of high-quality ultrasound
examinations. The guidelines reflect what the AIUM considers the minimum criteria for a
complete examination in each area but are not intended to establish a legal standard of
care. AIUM-accredited practices are expected to generally follow the guidelines with
recognition that deviations from these guidelines will be needed in some cases,
depending on patient needs and available equipment. Practices are encouraged to go
beyond the guidelines to provide additional service and information as needed.
But although the overall tone of ultrasound practice guidelines implies flexibility, these
are complex documents that, in fact, contain language from all categories, or levels, of
recommendations. From the AIUM Practice Guideline for the Performance of the
Musculoskeletal Ultrasound Examination, IV. Supervision and Interpretation of Ultrasound
Examinations:
“A physician must be available for consultation with the sonographer on a case-by-case
basis” (‘standard’ language).
“Ideally, the physician should be on-site and available to participate actively in the
ultrasound examination when required. It is recognized, however, that geographic
realities may not permit the presence of an on-site physician in all locations.” (‘guideline’
language).
“Throughout the examination of the rotator cuff, the cuff should be compressed to detect
nonretracted tears” (‘guideline’ language).
“In the evaluation of rotator cuff tears, comparison with the contralateral side may be
useful” (‘option’ language).
If guidelines are to help clinicians and patients make informed decisions, they must meet
the basic standards of technical documents: Considering the audience, guideline drafters must
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present well-informed, unbiased recommendations in using clear, unambiguous language, using
a user-friendly format.

But other factors affect recommendation strength as well. For example, during the Avian
flu epidemic, as soon as an effective treatment was discovered, a strong recommendation was
issued to provide that treatment to patients. No randomized controlled trial data with high quality
data supported the recommendation, but the risk of fatality and of spread of the disease was great.
Delaying treatment until it could be proven effective was not practical, and randomized control
trials would have been unconscionable.

Emerging Users and Appropriateness
When new approaches enter the patient care arena, they have not yet generated much
evidence from which to develop recommendations, and guideline development for evolving
ultrasound applications is controversial. The evidence problem associated with writing CPGs for
emerging applications was addressed by the 1993 Canadian Workshop on Clinical Practice
Guidelines. A summary of this group’s proceedings reports workshop participants’ discussions
of challenges and best approaches to developing clinical practice guidelines. One issue raised at
the workshop was the problem of writing guideline statements for newly evolving practices.
Although some members of the group did not support development of guidelines when evidence
was sparse, others felt that “scientific uncertainty” should not impede CPG development.
Attendees concluded that even when little relevant evidence exists and definitive statements are
not possible, guidelines can be written based on expert opinion, provided that the quality of
supporting evidence is properly characterized. To enhance validity of such guidelines, in the
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absence of substantial evidence these authors recommend a thorough explanation of methods,
with revisions as necessary to develop growing knowledge (1715-1719).
Most importantly, the document must provide evidence that every reasonable effort was
made to overcome bias. When recommendations proceed largely or entirely on expert opinion,
validity must be established through these features:


Guidelines development committee composition to include a broad spectrum of
perspectives



A well-documented, high quality, transparent collaborative process



Accurate characterization of evidence and recommendations



A built in method of gathering evidence prospectively to validate recommendations or to
inform revisions

Summarize the lit review, and lead into
………………………………………………………………………………………………………
……………………………………………

31

32

CHAPTER THREE: METHODOLOGY
In this chapter I present the criteria I used to analyze and rate technical writing attributes
of several current CPGs. The quality of these attributes influences the accuracy and readability of
guideline documents, and so affects their respective values as clinical tools. For a CPG to be
valuable to clinicians, and ultimately to patients, it must convey accurately characterized
information in clear, unambiguous language in a format and style that makes the information
accessible to the user. I propose that when a guideline meets the criteria I set forth in this chapter,
the guideline writing quality promotes the users’ needs for validity and usability. it 1) meets the
definition of validity and 2) it meets usability standards.
To begin, I discuss the background and the writing-specific features of Appraisal of
Guidelines Research in Evaluation (AGREE) instrument. Because of its demonstrated value and
its suitability to assessing technical communication, AGREE served as the foundation for the
rubric I developed. Next I describe variations in purpose and functionality among guidelines,
and I examine a guideline’s functional “category” as a crucial factor in the quality equation.
Finally, I advance a guideline assessment rubric I developed by combining selected items from
AGREE with additional criteria related to the nature of each category. In the chapter that
follows, I use this new tool to evaluate the quality of several CPGs.

The AGREE instrument
In the mid 1990s, the EU Biomedicine and Health Research Programme sponsored an
international meeting of researchers to consider the problem of variation in the quality of CPGs.
Included among the participants were representatives from Canada, Denmark, England, Finland,
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France, Germany, Italy, Netherlands, New Zealand, Spain, Scotland, Switzerland, and the United
States. These researchers collaboratively developed an instrument designed for use both as a tool
for assessing the quality of existing CPGs and as a guide to a “harmonious” development process.
Called the Appraisal of Guidelines Research an Evaluation (AGREE), the instrument evaluates
the quality of reporting found in CPG documents, and it assesses some aspects of the guideline
development process. The AGREE tool was extensively field-tested and validated through
application to a random sample of guidelines. AGREE is now looked to as a reference by
guideline developers all over the world.
AGREE provides structured assessments for six guideline “quality domains” identified
by its developers as fundamental to guideline quality. The quality domains include guidelines’ 1)
Scope and purpose, 2) Stakeholder involvement, 3) Rigour of development, 4) Clarity and
presentation, 5) Application, and 6) Editorial independence. Within each quality domain are
items that contribute to the domain’s objective. A total of 23 items comprise the AGREE
instrument.

Domain 1: Scope and Purpose
The first quality domain is that of “Scope and Purpose.” According to the criteria
outlined by AGREE, to justify the resources invested in development of a particular guideline,
the need for the guideline should be conveyed in its introduction. Also in the introduction, the
overall objectives of the guideline, the core clinical questions it will address, and the guideline’s
target patients should be stated. It is crucial for these introductory details of scope and purpose to
be clearly and unambiguously defined because they will direct the guideline development
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research and focus guideline developers’ recommendations. To meet AGREE’s scope and
purpose criteria:
Item 1. Statements should provide a rationale for the guideline, and address its expected
impact, i.e., improvement of a particular problem. Content should identify the guideline’s
expected result, target population, and category of care.
Item 2. The fundamental clinical questions, or interrogative statements, should be
detailed, and they should provide operational links to the key recommendations. Content should
define the intervention of interest, and when more than one intervention is considered, the
options should be compared. The guideline should also describe for whom the interventions are
being considered, the expected outcomes, and the treatment setting.
Item 3. Relevant characteristics of the target population should be reported, and
characteristics that would exclude some patients should be identified.

Domain 2: Stakeholder Involvement
AGREE’s second quality domain, “Stakeholder involvement,” assesses how effectively a
guideline development group represents the perspectives of patients and other individuals and
groups whose interests will be directly affected by the guideline. Underlying this domain’s
concern is dominance of special interests, and the potential for a biased development process that
could undermine the ethics and practicality of guideline application. For example, fetal
echocardiographic examinations are performed and interpreted by members of several different
clinical groups, including pediatric cardiologists, maternal fetal medicine specialists, and
specially trained obstetricians. If a guideline for performing fetal echoes is developed by a
committee that does not include members of one of those professional groups, the guideline may
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be weakened by omission of the group’s particular training pathway or its perspective on
examination components. If the insurer’s perspective is not considered, costs associated with
guideline recommendations could become contentious. If patients’ preferences are not
considered, there may be poor compliance with recommendations. To meet AGREE’s
stakeholder involvement criteria:
Item 6. Target user groups should be well defined to include all potentially qualified
providers, and the purpose of the guideline should be identified.

Domain 3: Rigor of Development
Quality Domain 3, “Rigor of Development,” evaluates a guideline’s scientific soundness.
This domain deals not with the intrinsic quality of the evidence, but, rather, with the methods
through which it is selected, interpreted, and translated into recommendations. The risk of bias
and of perpetuating outdated practices is reduced when guideline developers methodically search
the literature for relevant evidence sources, and then narrow the number of sources using
objective criteria, finally formulating recommendations based on an analysis of the evidence.
Thorough, accurate reporting of the development process is fundamental to establishing
guideline validity, and regular updating is essential to keeping recommendations aligned with
current evidence. To meet AGREE’s criteria for developmental rigor:
Item 8. Explicit definition of inclusion/exclusion criteria for evidence should be provided,
along with clear statement of rationale for the criteria.
Item 9. Strengths and weaknesses of each piece, or group of pieces, of evidence should
be described. Descriptions should focus on its inherent risk of bias, and on the method used by
guideline developers to interpret the evidence.
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Item 10. The collaborative method used to formulate recommendations should be
described, along with outcomes, areas of disagreement, and the level of consensus.
Item 12. Recommendations should be explicitly linked to their supporting evidence.
When evidence is sparse and a recommendation is based on expert consensus, the nature of the
link should be explicitly stated.
Item 14. A timetable and methodology for guideline update should be provided.

Domain 4: Clarity of Presentation
The next domain, Clarity of Presentation, evaluates document usability. While
background information and evidence analysis are crucial to guideline quality, for CPGs to be
useful to busy clinicians these documents must provide answers to their questions, and those
answers must be clear, unambiguous, and easy to find. Recommendations should be clear and
specific, and all options should be enumerated. When the guideline is lengthy or complex, the
most important recommendations should be grouped for easy access. To satisfy the criteria of
Domain 4:
Item 15. Recommendations should clearly specify and describe the option which was
determined from the evidence to be most appropriate for an identified population with particular
indications. Any uncertainty about recommendations should be disclosed in the guideline.
Item 16. Management guidelines should present all possible options and provide
guidance as to which option is most appropriate for each condition variation.
Item 17. Key recommendations should answer the central clinical questions. These
answers should be easy to find in the document.
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Domain 5: Applicability
The 5th domain of Applicability measures guideline features that promote its use and
usefulness. Guideline criteria may help clinicians assess and improve the quality of their care
practices, and they may be useful as measures of guideline effectiveness.
Item 19. To improve guideline effectiveness, advice and/or tools to enhance
dissemination and implementation should be provided
Item 21. To make guidelines part of an iterative health improvement process they should
include criteria and tools for measuring their use and impact. Effective criteria should proceed
directly from the key recommendations.

Domain 6: Editorial Independence
At issue in the final domain, Editorial Independence, is the concern for commercial
influences that may bias guideline developers. Interaction between clinicians and medical
industries is essential to advancing medical technology and pharmacology, but close commercial
relationships may color clinicians’ preferences when considering options. To comply with
AGREE’s Editorial Independence criteria:
Item 23. Members of a development group must declare any personal connection that
could bias their interpretation of the evidence. Any such declarations should be explicitly stated.
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Rubric Development
Rubric Version 1 (RV1)
As a first step in developing my rubric, I adopted 15 attributes from AGREE (Figure 1).
Items selected for inclusion in this first version of my rubric focused on document composition;
items focused entirely on methodology were omitted. For each guideline evaluated, the included
attributes will be rated for writing effectiveness on a 4-point scale, from “Strongly Disagree (1)”
to “Strongly Agree (4),” with comments as indicated.
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RUBRIC VERSION 1
ATTRIBUTE

1

2

3

4

Domain 1. Scope and Purpose
1. Guideline objectives
2. Clinical question(s)
3. Target population
4. AGREE item omitted
Domain 2. Stakeholder Involvement
5. AGREE item omitted
6. Target users
Domain 3 Rigor of Development
7. AGREE item omitted
8. Evidence selection criteria
9. Evidence strengths, limitations
10. Method for formulating
recommendations
11. AGREE item omitted
12. Link between evidence &
recommendations
13. AGREE item omitted
14. Updating procedure
Domain 4. Clarity of Presentation
15. Recommendations
16. Management options
17. Key recommendations
Domain 5. Applicability
18. AGREE item omitted
19. Implementation tools
20. AGREE item omitted
21. Monitoring &/or audit criteria
Domain 6. Editorial Independence
22. AGREE item omitted
23. Competing interests of CPG
development group

Figure 1: Rubric Version 1 (RV1)
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COMMENTS

Guideline categories: Qualifying the rubric
NGC currently publishes on its website summaries of more than 2500 CPGs. At their
cores, CPGs all serve one overarching purpose: to make valid recommendations that will assist
practitioners with health care decision-making. But CPGs address a broad spectrum of services
whose basic purposes and complexities differ, and I propose that these differences need to be
considered in the construction of guideline assessment tools.
Based upon the primary tasks addressed by each guideline, the NGC defines eleven
guideline categories. NGC Guideline Categories include:
Assessment of Therapeutic Effectiveness. This guideline’s function is to measure the
benefit of the practice in question, considering the effectiveness of the practice and its
acceptability to the patient.
Counseling. This guideline’s function is to recommend methods professionals may use to
educate or guide patients to better physical or emotional health.
Diagnosis. The function of this guideline is to recommend ways to identify and
differentiate clinical conditions. Guidelines in this category may describe a multi-step process to
include one or more branching decision junctures.
Evaluation. An evaluation guideline outlines a process for gathering information from
which a diagnosis and a possible treatment plan may be developed, or later in treatment to assess
its effectiveness.
Management. Management guidelines describe a comprehensive process of integrating
and implementing treatment and evaluation.
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Prevention. These guidelines recommend means to promote health and prevent physical
and mental disorders
Rehabilitation. These guidelines recommend interventions and techniques for restoring
well-being.
Risk Assessment. These guidelines recommend ways to assess the potential of harm
resulting from a negative health factor or the lack of a beneficial factor.
Screening. Guidelines in this category recommend means of early detection of disease or
the increased likelihood of disease.
Technology Assessment . These guidelines evaluate the use of a particular technology for
a clinical purpose, comparing it to other technologies used for the same application.
Treatment. These guidelines recommend interventions meant to relieve illness or injury.
Although the NGC describes these eleven separate “Guideline Categories,” in fact, most
guidelines are comprised of elements of more than one category, with most incorporating
“Treatment” (2481), “Management” (2240), and/or “Evaluation” (2168), along with elements of
other categories.

Guideline Category Assessment
I propose that functional differences among these various categories create differences in
the types of tasks they address, and that these differences are important variables to consider
when judging guideline quality.
To simplify guideline characterization by function, I suggest combining the eleven
guideline categories differentiated by the NGC into three larger groups according to general task
structures.
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Category Group 1: Stratified Recommendations
Of the eleven categories, five comprise guidelines that describe and compare options,
stratifying the options by appropriateness:


Assessment of therapeutic effectiveness



Diagnosis



Risk assessment



Technology assessment



Treatment
Guidelines in Category Group 1 (CG1) present evidence of relative effectiveness,

benefits, and risks of each available option. Based upon strength of evidence, guidelines in this
category stratify options and make corresponding practice recommendations. CG1 guidelines
essentially make decisions for clinicians, and so should provide compelling evidence that the
recommendations they advance are sound. Guidelines in this category may include evidence
tables and may define rubrics used to grade evidence and recommendations.

Category Group 2: Multi-option Recommendations
The guidelines in these next 4 categories offer multiple options, not strictly stratified and
not mutually exclusive:


Rehabilitation



Screening



Prevention



Counseling
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Guidelines in Category Group 2 (CG2) list options that can be used together, or in some
combination based on resources and patients’ preferences, to improve or promote well-being.
Compared to CG1 guidelines, these guidelines leave more decision-making to the clinician. To
support informed clinical decisions, CG2 guidelines should provide evidence of some measure of
effectiveness, if not clear superiority, of each listed option for identified clinical variants.

Category Group 3: Performance Recommendations
Guidelines in the last two categories recommend a process for technical performance of a
single, or of a bundled, intervention.


Evaluation



Management
Guidelines in Category Group 3 (CG3) serve as performance manuals. These guidelines

instruct clinicians on how to perform a particular task, or tasks. While there is an important role
for evidence in these guidelines, particularly with respect to exam appropriateness and the
composite of steps required to complete these tasks, the guideline body – the technical
instruction – does not lend itself to “stratified evidence.” Category 3 Guidelines must be based
on the experience and opinions of individuals who are experts at these tasks.
In summary, these criteria that relate to guideline categories will be addressed in my
rubric:
CG1 Stratified Recommendation guidelines promote one option over others.
Stratification should be based on high quality evidence demonstrating clear advantage(s) of the
recommended option. The evidence should be presented in clear, unambiguous, unbiased
language, with devices that simplify data interpretation.
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CG1 guidelines appropriate decision-making, and so should prove superiority of
recommended options.
CG2 Multi-Option Recommendation guidelines provide multiple, largely non-stratified,
options. Guidelines in this category should facilitate clinicians’ decision-making by providing
thorough, broadly comprehensive information about each option and its possible application.
CG2 guidelines inform decision-making and so should demonstrate effectiveness and
application of recommended options.
CG3 Performance guidelines lead clinicians through processes. These guidelines should
conform to the standards of high-quality user manuals.
CG3 guidelines recommend performance methods, and so should establish through
references that they are informed by expert opinion, and they should meet the standards of
performance manuals.

Adjusting the Rubric for Category Differences
Next I re-evaluated my rubric, considering the characteristics of each Category Group.
Weighing the fundamental information and burden of evidence necessary for each, I determined
which RV1 attributes related to those guideline requirements. The following table (Table 1)
presents my assessment of the relevance of attributes to guideline categories and, in turn, to the
measure of their quality.
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Table 1: Category Relevance
Domain.Item
Attribute
1.1
1.2
1.3
2.6
3.8
3.9
3.10
3.12
3.14
4.15
4.16
4.17
5.19
5.21
6.23

Guideline objectives
Clinical question(s)
Target population
Target users
Evidence selection criteria
Evidence strengths, limitations
Method for formulating recommendations
Link between evidence & recommendations
Updating procedure
Recommendations
Management options
Key recommendations
Implementation tools
Monitoring &/or audit criteria
Competing interests of CPG development
group

Category Relevance
CG1
CG2
CG3
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√

According to this assessment, 11 of the RV1 items are relevant to all guideline categories.
The remaining items, numbers 3.8, 3.9, 3.10, and 3.12, are necessary for CG1 guidelines to
establish superiority of the recommended options, and to CG2 guidelines to demonstrate the
effectiveness of recommended options. I propose that those items are not, however, relevant to
CG3 guidelines whose function is not to promote options, but, rather, to recommend
performance methods.
While CG3 guidelines do not need to meet all of the criteria set forth by AGREE, I
propose that, related to their function as performance manuals, guidelines in this category need to
meet some requirements not included in AGREE. According to Gerson (362), user manuals
should present clearly defined, well-developed steps and exhibit effective document design.
These two attributes, essentially an extension of AGREE Domain 4, should be considered when
assessing CG3 Guideline quality, so I will add them to my Rubric Version 1. Guidelines in CG3
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also need to establish ethos by referencing expert opinion to support recommended procedures,
so I will add an item for that attribute as well.
In addition to the three just-described attributes, I propose that one more is essential to
the quality of guideline documents in the CG3 group: justification for performance. Particularly
for emerging ultrasound applications where evidence of procedure benefit is sparse, establishing
appropriateness will be of critical importance to prevent their misuse and overuse.
Finally, after review of several guidelines, I conclude that guideline documents vary in
the quality of their organization, which affects their usability. Including the 4 additional quality
attributes to be measured in CG3 guidelines, and adding logical presentation as an assessment
item for all groups, I propose this revised list of quality attributes. (See Table 2.) Check marks
indicate relevant attributes for guidelines in each category.
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Table 2: Category-Adjusted Guideline Quality Assessment
Item
Attribute
#
1. Guideline objectives
2. Health question(s)
3. Target population
4. Target users
5. Evidence selection criteria
6. Evidence strengths, limitations
7. Method for formulating recommendations
8. Link between evidence & recommendations
9. Updating procedure
10. Recommendations
11. Management options
12. Key recommendations
13. Implementation tools
14. Monitoring, audit criteria, and future research
15. Competing interests of CPG development group
16. Logical presentation
17. Clearly defined steps
18. Effective document design
19. Expert reference
20. Appropriateness criteria

Guideline Category
CG1
CG2
CG3
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√

From the assessment rubric just described, I created the following worksheet (See Figure
2) to use when evaluating guidelines in Chapter 4.
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Guideline Title:
Guideline Developer:
Guideline Category(s): GC1 ___________ GC2 ____________ GC3___________
Instructions:
Rate Items 1 – 12 for ALL Guidelines.
4 = Strongly Effective
3 = Moderately Effective
2 = Moderately Ineffective
1 = Strongly Ineffective, or Missing
GC1 and GC2 Guidelines: Rate Items 13 – 16 *
GC3 Guidelines : Rate Items 17 – 20 **

#

ATTRIBUTE

1
2
3
4
5
6
7
8
9
10
11
12

Guideline objectives
Health question(s)
Target population
Target users
Updating procedure
Recommendations
Management options
Key recommendations
Implementation tools
Monitoring, audit criteria, and future research
Competing interests of CPG development group
Logical presentation

13
14
15
16

Evidence selection criteria
Evidence strengths, limitations
Method for formulating recommendations
Link between evidence & recommendations

17
18
19
20

Appropriateness criteria
Clearly defined steps
Effective document design
Expert reference

RATING
1 2 3 4

COMMENTS

*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY!

**Rate Items 17 – 20 for CG3 guidelines ONLY!

TOTAL SCORES:
Figure 2: Category-Adjusted Guideline Assessment Tool

= ______________

In Chapter Four, I present my analyses of six clinical practice guidelines that address
various ultrasound applications. Using the rubric above, I assess text components of these
documents and rate how effectively each one promotes guideline validity and usability.
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CHAPTER FOUR: ANALYSIS
In this chapter I present my analyses of six clinical practice guidelines that address
various ultrasound applications. Using the rubric I described in Chapter Three, I assess text
components of these documents and rate how effectively the writing supports each attribute and
promotes guideline validity and usability. Although I assign a score to attributes and to each
document overall, the primary purpose of my assessments is to identify writing practices that
weaken guidelines and to highlight practices that make the documents strong. With this study I
evaluate features and writing challenges fundamental to CPGs, but I direct special focus toward
those attributes that may prove most important, and most challenging, for developers of
guidelines for emerging ultrasound applications. I believe findings and conclusions from these
analyses may be used by guideline drafters to enhance the quality of CPGs for emerging users.

Guideline Assessments
The six CPGs I selected all address topics related to ultrasound, but they span a broad
spectrum of settings, target user groups, and types of applications. Where two guidelines are
published by the same organization, I review them together, describing common features and
noting differences.

Guideline 1: American College of Emergency Physicians
Critical issues in the initial evaluation and management of patients presenting to the emergency
department in early pregnancy (2003)
The first two guidelines I review are published by the American College of Emergency
Physicians (ACEP). The first of these, the earliest published among this group, is ACEP’s
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Clinical Policy: Critical Issues in the Initial Evaluation and Management of Patients Presenting
to the Emergency Department in Early Pregnancy. This ten-page guideline written in 2003
describes point-of-care ultrasound as one component of a diagnostic plan. The guideline is
composed of seven sections. In the first section, the “Introduction,” the guideline’s rationale and
critical issues are provided. Section 2, “Methodology,” describes the literature review method
and criteria for ranking evidence and for grading recommendations. Section 3, “Critical
Questions,” presents diagnostic questions related to interpretation of blood pregnancy test results.
For each question, recommendations follow a review of relevant evidence. Two of these three
questions relate blood test results to findings from point-of-care ultrasound examination. The 4th
and 5th sections, “Methotrexate in Ectopic Pregnancy” and “Rh Seroconversion and Indications
for Anti-D Immunoglobulin,” appropriateness of these treatments is questioned. Following a
review of the evidence for each, patient management recommendations are provided. No
questions are identified for sections 6, “Threatened or Complete Abortion or Ectopic
Pregnancy,” or 7, “Minor Abdominal Trauma,” but evidence related to the conditions is
discussed, with recommendations following. After the body of the guideline, members of the
document development group are listed. References listed at the end of the guideline are also
embedded in the text to indicate support for evidence statements.
Using the Category-Adjusted Guideline Quality Assessment Worksheet I prepared in
Chapter 3, I rated attributes of this guideline. The findings are presented below in Table 3.
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Table 3: Clinical Policy: Critical Issues in the Initial Evaluation and Management of Patients
Presenting to the Emergency Department in Early Pregnancy (2003)
Guideline Developer: American College of Emergency Physicians
Guideline Category(s):

GC1 ___x___

GC2 ______ GC3 ______

Instructions:
Rate Items 1 – 12 for ALL Guidelines.
4 = Strongly Effective
3 = Moderately Effective
2 = Moderately Ineffective
1 = Strongly Ineffective, or Missing
GC1 and GC2 Guidelines: Rate Items 13 – 16 *
GC3 Guidelines : Rate Items 17 – 20 **
#

ATTRIBUTE
1 Guideline objectives

RATING
4 3 2 1
x

2 Health question(s)

x

3 Target population
4 Target users

x
x

5 Updating procedure

x

6 Recommendations

x

7 Management options

x

COMMENTS
Clear statement of clinical imperative
and topics.
(see comments below)
“Critical Questions” are explicit,
bolded, prominently located, and
numbered for easy identification.
(see comments below)
The title specifies the target population.
The target user group is defined
(see comments below)
A plan for guideline review and
updating was provided.
(see comments below)
Recommendations use unambiguous,
directive language and directly state
justification for each recommendation.
Strength grades are included with each
recommendation.
(see comments below)
For a particular setting, 2 options were
discussed, and option selection
guidance was provided.
(see comments below)
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#

ATTRIBUTE
8 Key recommendations

RATING
x

9 Implementation tools

x

10 Monitoring, audit criteria,
and future research

11 Competing interests of
CPG development group
12 Logical presentation

x

COMMENTS
Key recommendations appear as
responses to specific health questions.
Recommendations are easily found
under informative, bolded headings.
The recommendations are easy to
access, but the guideline could be
enhanced with additional
implementation tools.
x None of the recommendations meet the
developers’ criteria for Level A
strength, so the value of the guideline
might be enhanced by specific
suggestions for further research.
x No conflict of interest disclosures
appear in the guideline.
Easy to follow progression from
clinical question through evidence to
recommendations.

*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY!
13 Evidence selection criteria x
Details of search and selection process
are provided.
(see comments below)
14 Evidence strengths,
x
The method of interpreting evidence
limitations
and guarding against biased
recommendations was described.
(see comments below)
15 Method for formulating
x
The method is explicitly described.
recommendations
(see comments below)
16 Link between evidence &
x
Each clinical question is explicitly
recommendations
answered with review of relevant
literature, and recommendations are
provided as conclusions from the
evidence.
(see comments below)
**Rate Items 17 – 20 for CG3 guidelines ONLY!
17 Appropriateness criteria
18 Clearly defined steps
19 Effective document design
20 Expert reference
TOTAL SCORES:

5
2

2

1

= ______55 / 64________
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COMMENTS
1. Guideline objectives.
“In the past decade, despite major changes in epidemiology, incidence, and demographic,
ectopic pregnancy remains the most common cause of maternal death and serious morbidity in
the first trimester of pregnancy. For this reason, critical issues selected for this policy revision
are those primarily associated with initial evaluation and management of ectopic pregnancy…
Those critical issues include: (1) … , (2)… , and (3) … .”
“This policy revision presents evidence for answering important questions about these
critical diagnostic and management issues.”
2.

Clinical questions.
“Is transvaginal ultrasound useful in detecting intrauterine pregnancy when the serum

hCG level is less that 1,000 mIU/mL?”
“Is transvaginal ultrasound useful in detecting ectopic pregnancy when the serum hCG
level is less than 1,000 mIU/mL?”
“What is the role…?” etc.
4.

Target users.
“This guideline is intended for physicians working in hospital-based emergency

departments.”
5.

Updating procedure.
“Clinical policies are scheduled for revision every 3 years; however, interim reviews are

conducted when technology or the practice environment changes significantly.”
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6.

Recommendations.
“Level B recommendations. Obtain a repeat serum hcG determination at least 2 days after

the initial presentation because it is useful in characterizing the risk of ectopic pregnancy and the
probability of a viable intrauterine pregnancy.”
7.

Management options.
“Because the symptoms associated with gastrointestinal side effects of methotrexate

therapy may mimic an acute ectopic rupture, rule out ectopic rupture resulting from treatment
failure before attributing gastrointestinal symptoms to methotrexate toxicity. “
13.

Evidence selection criteria.
“Abstracts and articles were reviewed by subcommittee members, and pertinent articles

were selected. These were evaluated, and articles addressing the questions considered in this
document were chosen …”
14.

Evidence strengths/limitations.
“All publications were graded by at least 2 of the subcommittee members…”
“Factors such as heterogeneity of results, uncertainty about effect magnitude and

consequences, strength of prior beliefs, and publication bias…might lead to a downgrading of
recommendations.”
15.

Method for formulating recommendations.
“During the review process, all articles were given a baseline ‘strength of evidence’ by

the subcommittee members according to [explicitly stated] criteria.” “Recommendations
regarding patient management were then made according to [explicitly stated] criteria.”
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16.

Link between evidence and recommendations.
The clinical question: “Is transvaginal ultrasound useful in detecting intrauterine

pregnancy when the serum hCG level is less than 1,000 mIU/mL?”
The evidence: From cited study #1: “All 9 pregnancies were correctly identified …from
300 mIU/mL and 1,000 mIU/mL” From study #2: “… correctly diagnosed … 800 mIU/mL.”
From additional studies similar evidence was reported.
The recommendation: “Consider transvaginal ultrasound because it may detect
intrauterine pregnancy when the serum hCG level is below 1,000 mIU/mL.”

Guideline 2. American College of Emergency Physicians
Clinical Policy: Critical Issues in the Evaluation and Management of Emergency Department
Patients With Suspected Appendicitis (2010)
The second ACEP guideline, Clinical Policy: Critical Issues in the Evaluation and
Management of Emergency Department (ED) Patients With Suspected Appendicitis was
published 7 years later in 2010. In this much lengthier 35-page document the authors describe a
management plan for patients who visit the ED with complaints of acute abdominal pain. In the
“Introduction” and “Methodology” sections of this guideline, the information provided is similar
in type to the information provided in corresponding sections of the early pregnancy guideline.
There are, however, some important differences between the two guidelines. ACEP's
2002 guideline on managing pregnant patients in the ER lists the names of development group
members at the end of the guideline; this 2010 guideline from ACEP lists the development group
on the cover, with their titles expanded to include their titles and institutional affiliations. Among
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the 2002 developers, no one is described as a methodologist; from the 2010 group, two
methodologists are identified.
The format for reporting recommendations has evolved as well. In the 2002 guideline
each explicit health question is followed by a review of the literature that addresses the question.
Resulting recommendations follow the literature review. The format of the 2010 guideline
enhances usability by providing the recommendations immediately after the questions they
answer, with the literature review following the recommendations. While the format used by
guideline developers in 2002 was logical, the newer format is more user-friendly. In addition to
the narrative lit reviews in the body of the guideline, the 2010 guideline provides study analyses
in evidentiary tables. A comparison of these two guidelines reveals maturation of the guideline
development process with attention to easier user access and greater transparency.
In Table 4, below, I present attribute ratings for the second guideline.
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Table 4: Clinical Policy: Critical Issues in the Evaluation and Management of Emergency
Department Patients With Suspected Appendicitis (2010)
Guideline Developer: American College of Emergency Physicians
Guideline Category(s): GC1 ___x___

GC2 __X____ GC3 ______

Instructions:
Rate Items 1 – 12 for ALL Guidelines.
4 = Strongly Effective
3 = Moderately Effective
2 = Moderately Ineffective
1 = Strongly Ineffective, or Missing
GC1 and GC2 Guidelines: Rate Items 13 – 16 *
GC3 Guidelines : Rate Items 17 – 20 **
#

ATTRIBUTE
1 Guideline objectives

4
x

2 Health question(s)

x

3 Target population

x

4 Target users

x

5 Updating procedure

x

RATING
COMMENTS
3 2 1
The diagnostic challenge, and clinical
and legal impacts of the clinical
problem are discussed; Guideline goals
are stated.
(see comments below)
Questions define patient groups and
imaging options considered, and they
provide framework for comparisons.
Questions are prominently located,
bolded, and numbered for easy
identification.
(see comments below)
Along with the overall target
population, subgroups of interest are
identified, as well as excluded groups.
(see comments below)
The intended user group is defined,
and all groups who contributed to
development of the CPG were listed.
Intended use of the guideline is
described.
(see comments below)
A plan for guideline review and
updating was provided.
(see comments below)
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#

ATTRIBUTE
6 Recommendations

x

RATING

7 Management options

x

8 Key recommendations

x

9 Implementation tools

COMMENTS
Recommendations are graded for
strength; justification is provided in the
literature review immediately
following. Recommendations are
written using unambiguous, directive
language.
(see comments below)
For a particular setting, 2 options were
discussed and option selection
guidance was provided.
(see comments below)
Key recommendations immediately
follow questions to which they
respond. Recommendations are easily
found under informative, bolded
headings.
The recommendations are easy to
access, but the guideline could be
enhanced with additional
implementation tools.
Future areas of research are suggested
to improve answers to the guideline’s
questions.
(see comments below)
The guideline contains a bolded
conflict of interest disclosure.
(see comments below)
Direct, uncluttered connection between
questions and recommendations.

x

10 Monitoring, audit criteria,
and future research

x

11 Competing interests of
CPG development group

x

12 Logical presentation

x

*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY!
13 Evidence selection criteria x
The Methodology section details the
literature search and selection
parameters.
14 Evidence strengths,
x
Evidence is reviewed both as a
limitations
narrative to answer each question, and
in evidentiary tables.
(see comments below)
15 Method for formulating
x
The method is explicitly described.
recommendations
(see comments below)
16 Link between evidence &
x
Guideline drafters’ interpretive link
recommendations
between evidence and
recommendations is reported.
(see comments below)
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#

ATTRIBUTE

RATING

COMMENTS

**Rate Items 17 – 20 for CG3 guidelines ONLY!
17 Appropriateness criteria
18 Clearly defined steps
19 Effective physical design
20 Source of expertise
identified
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TOTAL SCORES:

= ______62 / 64________

COMMENTS
1.

Guideline objectives.
“Abdominal pain is a high-volume, high-risk chief complaint… The diagnosis of

appendicitis can be challenging even in the most experienced of clinical hands.”
“A writing subcommittee reviewed the literature to derive evidence-based
recommendations to help clinicians answer [these] critical questions [related to management of
emergency department patients with abdominal pain]: (1)…, (2) …, (3) … .”
2.

Health questions.
“Can clinical findings … guide decision-making…?
“… what is the role of contrast?”
“… what are the roles of CT and ultrasound in diagnosing acute appendicitis?”

3.

Target population.
“This guideline is intended for patients presenting to the ED with acute, nontraumatic

abdominal pain and possible or suspected appendicitis.”
“In adult patients with suspected acute appendicitis…”
“In children with suspected acute appendicitis…”
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“… not intended to address the care of patients with trauma-related abdominal pain, or
pregnant patients.”
4.

Target users.
“This guideline is intended or physicians working in hospital-based EDs.”
“This policy is not intended to be a complete manual on the evaluation and management

of patients with nontraumatic acute abdominal pain but rather a focused examination of critical
issues that have particular relevance to the current practice of emergency medicine…this
guideline defines for the physician those strategies for which medical literature exists to provide
support for answers to the crucial questions addressed in this policy.”
5.

Updating procedure.
“Clinical policies are scheduled for revision every 3 years; however, interim reviews are

conducted when technology or the practice environment changes significantly.”
6.

Recommendations.
“In children, use ultrasound to confirm acute appendicitis but not to definitively exclude

acute appendicitis.
7.

Management options.
“Given the concern over exposing children to ionizing radiation, consider using

ultrasound as the initial imaging modality. In cases in which the diagnosis remains uncertain
after ultrasound, CT may be performed.”
10.

Monitoring &/or audit criteria/Research.
Guideline question 2”In adult patients with suspected acute appendicitis who are

undergoing a CT scan, what is the role of contrast?”
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Research suggestion 1: “A prospective comparison of CT with no contrast, IV contrast
alone, and oral and IV contrast (for appendicitis), using the newest CTG technology. This study
could be done in both adult and pediatric populations.”
11.

Competing interests of CPG development group.
“There were no relevant industry relationships disclosed by the subcommittee

members…”
14.

Evidence strengths, limitations.

In evidentiary tables each study is analyzed by year, design, intervention, outcome
measure, results, limitations, and class.
15.

Method for formulating recommendations.

“All articles used in the formulation of this clinical policy were graded by at least 2
subcommittee members for strength of evidence and classified by the subcommittee members in
to 3 classes of evidence on the basis of…”
“Articles were then grade on 6 dimensions thought to be most relevant to the
development of a clinical guideline: …”
“Articles received a final grade …”
“Clinical findings and strength of recommendations regarding patient management were
then made according to the following criteria:
Level A recommendations…
Level B…
Level C …”
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16.

Link between evidence & recommendations.
“Theoretically, higher Alvarado scores are associated with a higher likelihood of

appendicitis and lower scores with a lower likelihood of appendicitis. Whether the Alvarado
score can reliably predict the need for CT is debatable. [cited studies discussed] The authors
concluded that patients with scores of 3 or less should not have CT, those with scores between 4
and 6 should have CT, and those with scores 7 or higher… The authors recommended imaging
even patients with low Alvarado scores.”

Guideline 3: American Urological Association
Consensus Statement on Urologic Ultrasound Utilization (2007) (Analysis: Table 5)
The third guideline was first published by the American Urological Association (AUA) in
1993 and periodically revised, most recently in 2007. The guideline is presented in five sections:
Section 1, the “AUA Policy Statement on Imaging Services,” affirms urologists as qualified to
perform ultrasound as part of their patient care. “Section 2, “Equipment, Documentation,
Indications,” is the operational part of the guideline. This section begins with general
recommendations for equipment and for documentation standards, and then follows with targeted
details, technique instructions, and indications for six ultrasound exams performed by these users.
This largest section is followed by a discussion of “Educational Requirements” set forth by this
organization for their members who perform ultrasound, and it details the curriculum of the
ultrasound component of Urology Residency Education. Next, Section Five, “Patient Safety,”
provides a statement about responsible use of ultrasound.
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This guideline is generally easy to follow with bulleted lists and good use of white space.
Its explanations of technique, however, are embedded in text, rather than presented in a more
user-friendly list format. Table 5 reports attribute ratings.
Table 5: Consensus Statement on Urologic Ultrasound Utilization (2007)
Guideline Developer: American Urological Association (2007)
Guideline Category(s) : GC1 _____

GC2 ______ GC3 ____X__

Instructions:
Rate Items 1 – 12 for ALL Guidelines.
4 = Strongly Effective
3 = Moderately Effective
2 = Moderately Ineffective
1 = Strongly Ineffective, or Missing
GC1 and GC2 Guidelines: Rate Items 13 – 16 *
GC3 Guidelines : Rate Items 17 – 20 **
#

ATTRIBUTE
1 Guideline objectives
2 Health question(s)
3 Target population
4 Target users

5 Updating procedure
6 Recommendations

7 Management options

RATING
COMMENTS
4 3 2 1
x
Objectives are not clearly defined.
x
No clinical questions are provided to
link exam indications to recommended
practices
x
The population is characterized per
indications, but no other patient
descriptions are provided.
x
Urologists are identified as target users;
suitability of these users is strongly
affirmed.
(see comments below)
x No plan is provided.
x
Equipment, performance, and
documentation recommendations are
provided, and their relative strengths
are characterized. (see comments
below)
x
When more than one approach may be
used, all are clearly stated.
(see comments below)
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#

ATTRIBUTE
8 Key recommendations

RATING

9 Implementation tools
10 Monitoring, audit criteria,
and future research
11 Competing interests of
CPG development group
12 Logical presentation

x

COMMENTS
x Recommendations are described, but
none are easily identified as key
answers to clinical questions.
x No guideline implementation tools are
provided or suggested.
x No assessment criteria are provided.
(see comments below)
x Conflict of interest statements are not
provided.
Global statements begin and end the
guideline, with individual exams
grouped under descriptive headings.

*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY!
13 Evidence selection criteria
14 Evidence strengths,
limitations
15 Method for formulating
recommendations
16 Link between evidence &
recommendations
**Rate Items 17 – 20 for CG3 guidelines ONLY!
17 Appropriateness criteria
x
Provides opinion that patient care is
optimized when urologists perform
their patients’ ultrasound exams, but
does not offer supporting literature.
(see comments below)
18 Clearly defined, ordered
x
Steps are clearly stated and concise, but
steps
they are grouped in paragraphs, making
the beginning of each step difficult to
locate.
19 Effective document design
x
Instructions are compressed into dense
paragraphs. The user would follow the
instructions more easily if steps were
separated and numbered. No graphics
are included.
20 Expert reference
x
AUA, an organization of urologists, is
defined as the guideline developer.
TOTAL SCORES :

2
0

4

8

5

= ______37 / 64________
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COMMENTS
4.

Target users.
“The AUA affirms that urologists are the physicians best qualified to diagnose, manage

and treat diseases and conditions of the genitourinary tract in patients of all ages.”
“Urologists combine the technical skill in the use of imaging equipment with the
cognitive skills of the underlying disease process…”
“The acquisition and maintenance of skills and knowledge associated with imaging
technology is assured by the Accreditation Council for Graduate Medical Education residency
review committee for urology…”
Note: Section 3, Educational Requirements, details the ultrasound training residents
receive, listing didactic areas of instruction and describing hands-on training. Post-residency
training is also described, and the extent of ultrasound knowledge tested for urology certification
is characterized. This method of defining training guidelines may be of value as a model for
other emerging user groups.
6.

Recommendations
“The equipment should display mechanical and thermal indices and provide for adjusting

power output.”
“An antibiotic may be administered if biopsy is anticipated.”
“A moderately filled bladder is necessary for optimal imaging of the bladder.”
7.

Management options
“The needle guide may be a single-use device or a reusable device.”

66

“The bladder should be scanned in the transverse and sagittal views. Bladder imaging can
also be performed using [approach 1] or [approach 2]. It may also be performed by [approach 3]
using special ultrasound transducers…”
10.

Monitoring &/or audit criteria
Note: Patient satisfaction and outcomes studies could be recommended to evaluate

appropriateness of urologists performing ultrasound exams
17.

Appropriateness criteria
“Urologists integrate an understanding of the risks and benefits of imaging technologies

with the clinical care of the patient. Patient care is optimized when urologists coordinate the use
of appropriate imaging techniques and equipment in the setting most beneficial to their patients.”

Guideline 4: American College of Cardiology Foundation, et al
2008 Appropriateness Criteria for Stress Echocardiography: A Report of the American College
of Cardiology Foundation Appropriateness Criteria Task Force, American Society of
Echocardiography, American College of Emergency Physicians, American Heart Association,
American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and
Interventions, Society of Cardiovascular Computed Tomography, and Society for
Cardiovascular Magnetic Resonance Endorsed by the Heart Rhythm Society and the Society of
Critical Care Medicine. (Analysis: Table 6)
The fourth guideline explores appropriateness concerns for this traditional ultrasound
application. The text of this 22-page strongly collaborative document is preceded by a list of
guideline developers and their affiliations.
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This guideline addresses the dual tasks of promoting optimal patient outcomes and
maintaining cost-effectiveness. Following an Abstract, the document contains eight major
sections, including ten tables. In the first section, the “Preface,” the guideline objective is stated,
along with a description of the collaborative appropriateness-rating process employed by the
committee. The second section, the “Introduction,” explains the guideline’s rationale, and in the
next section, “Methods,” the drafters describe the formal consensus method used to reduce bias
in this largely expert opinion-based guideline. The fourth section defines abbreviations. The fifth
section provides a general discussion of Results of Ratings, followed in sections six and seven
with reports of scores of Stress Echocardiography Appropriateness Criteria by Indication and by
Appropriateness Category, respectively. Section Eight provides a General Discussion of the
usefulness and limitations of appropriateness criteria, and of potentially valuable research
projects. Finally, the guideline concludes with references and four appendices. Appendices
include an assessment algorithm and financial disclosures, and expand on definitions, guideline
development methods, and compositions of working groups.
Stress echocardiographic examinations, the subject of this guideline, have been
performed by “traditional” users for more than a decade, but the major challenge inherent in
development of this CPG underlies guideline development for emerging applications: scarce data,
compelling a need to rely largely on expert opinion to generate recommendations. Methods used
by these guideline drafters to reduce bias and promote validity may be useful to drafters of
guidelines for emerging ultrasound applications.
Exam appropriateness is also likely to be a crucial issue for emerging ultrasound
applications, and the introduction to this guideline effectively summarizes the issue. According
to these authors, technological improvements have increased ultrasound’s diagnostic utility, but
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along with that benefit have come increased possibilities of misuse and overuse of the modality.
The authors raise concerns that this ultrasound examination may be prescribed for patients who
will not benefit from it, or who may benefit but could have been managed effectively without it.
Beyond the immediate expense of an unnecessary exam, the authors point out the danger of
exam results prompting “harmful and costly downstream testing” or unnecessary follow-up
exams. Rating of this guideline’s attributes follow in Table 6.
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Table 6: Appropriateness Criteria for Stress Echocardiography (2008)
Guideline Developer: American College of Cardiology Foundation Appropriateness
Criteria Task Force, American Society of Echocardiography, American College of
Emergency Physicians, American Heart Association, American Society of Nuclear
Cardiology, Society for Cardiovascular Angiography and Interventions, Society of
Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic
Resonance.
Guideline Category:

GC1 ___x______

GC2 _________ GC3 _________

Instructions:
Rate Items 1 – 12 for ALL Guidelines.
4 = Strongly Effective
3 = Moderately Effective
2 = Moderately Ineffective
1 = Strongly Ineffective, or Missing
GC1 and GC2 Guidelines: Rate Items 13 – 16 *
GC3 Guidelines : Rate Items 17 – 20 **
#

ATTRIBUTE
1 Guideline objectives

4
x

2 Health question(s)

x

3 Target population

x

4 Target users

x

5 Updating procedure

RATING
3 2 1

x

COMMENTS
Objectives and expected outcomes
from the guideline are described
(See comments below)
Questions concerning appropriateness
of the procedure for identified
indications are provided graphically in
tabled lists.
(See comments below)
The target population is broadly
defined, and then differentiated into
several smaller groups according to
their symptoms and clinical conditions.
(See comments below)
Clinicians, facilities, and payers are
identified as target users, and
suggestions are provided as to how the
document might be used.
(See comments below)
Necessity for updating was
acknowledged, but no plan was
provided.
(See comments below)
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#

ATTRIBUTE
6 Recommendations

x

RATING

7 Management options

x

8 Key recommendations

x

9 Implementation tools

x

10 Monitoring, audit criteria,
and future research

x

11 Competing interests of
CPG development group

x

12 Logical presentation

x

COMMENTS
Recommendations take the form of
quantitative appropriateness rating of
the procedure for each clinical variant.
(See comments below)
The document provides guidance on
how to use appropriateness scores.
Appropriateness ratings are easily
found in the guideline’s tables.
The tables are well-formatted and easy
to reference.
Areas wherein future research is needed
are described.
(See comments below)
A strong, specific statement addresses
potential relationships between CPG
developers and industrial interests.
Additionally, each author’s
professional affiliation and role in the
CPG development process is listed.
(See comments below)
A table of contents demonstrates a
logical, easily accessible document
structure.

*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY!
13 Evidence selection criteria x
“Relevant guidelines,” along with their
reference lists, were identified as the
sources of evidence. Key words are
provided with the reference list.
14 Evidence strengths,
x
The considered evidence is
limitations
qualitatively described as “relevant,”
“objective,” and “nonbiased,” but no
formal evidence-grading system is
provided.
(See comments below)
15 Method for formulating
x
This guideline draws strongly on
recommendations
judgment and expert opinion for its
recommendations. The committee’s
formal use of a modified Delphi
exercise is reported, and other steps the
committee took to reduce the risk of
bias are described.
(See comments below)
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# ATTRIBUTE
16 Link between evidence &
recommendations

RATING
x

COMMENTS
The role of expert consensus as the link
is explicitly stated.
(See comments below)

**Rate Items 17 – 20 for CG3 guidelines ONLY!
17 Appropriateness criteria
18 Clearly defined steps
19 Effective document design
20 Expert reference
5
4
TOTAL SCORES:
6
= ______60/64________

COMMENTS
1.

Guideline objectives.
“In an effort to respond to the need for the rational use of imaging services in the

delivery of high quality care, the American College of Cardiology Foundation (ACCF) has
undertaken a process to determine the appropriateness of cardiovascular imaging for selected
patient indications.”
“The ultimate objective of appropriateness criteria is to improve patient care and health
outcomes in a cost-effective manner but is not intended to ignore ambiguity and nuance intrinsic
to clinical decision making.”
“The primary objective of this report is to provide guidance regarding the perceived
suitability of stress echocardiography for diverse clinical scenarios.”
2.

Health question(s).
Comment: Fifty-one indications were evaluated and questioned as to appropriateness.

The guideline developers succeeded in presenting this large number of questions concisely by
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listing them in tables. The questions were made even more accessible by being grouped
according to several variations in the clinical scenario.
3.

Target population.
“All indications are assumed to apply to adult patients (18 years of age or older).”
Comment: Table headings further differentiate the population.

4.

Target users.
“Clinicians could use the ratings as a decision support or educational tool when ordering

a test or providing a referral to another qualified physician. The criteria also may be used to
facilitate discussion with referring clinicians who have patterns of ordering tests for
inappropriate indications. Facilities and payers may choose to use the criteria either
prospectively in the design of protocols, automated order entry, and pre-authorization procedures,
or retrospectively for quality reports. It is hoped that payers will use this document as the basis to
inform rational strategies to ensure that their members receive the highest-quality, cost –effective
cardiovascular care.”
“When used to assess performance, appropriateness criteria should be applied in
conjunction with systems that support quality improvement.”
5.

Updating procedure.
“It will be necessary to periodically assess and update the indications and criteria as

technology evolves and new data and field experience become available.”
6.

Recommendations.
“Score 7 to 9” – Appropriate
“Score 4 to 6” – Uncertain
“Score 1 to 3” – Inappropriate
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7.

Management options.
“If major risk predictors are present, Figure A1 suggests consideration of coronary

angiography and postponing or canceling noncardiac surgery. Once perioperative risk predictors
are assessed based on the algorithm, then the surgical risk and patient’s functional stats should be
used to establish the need for noninvasive testing.”
10.

Monitoring, audit criteria, and future research.
“Future research analyzing patient outcomes utilizing indications rated appropriate would

help ensure the equitable and efficient allocation of resources for diagnostic studies. Review of
medically necessary care may also improve the understanding of regional variations in imaging
utilization. Further exploration of the indications rated as “uncertain” will help generate the data
required to further define the appropriateness of stress echocardiography. Finally, it will be
necessary to periodically assess and update the indications and criteria as technology evolves and
new data and field experience become available.”
11.

Competing interests of CPG development group.
“The ACCF and its partnering organizations rigorously avoid any actual, perceived, or

potential conflicts of interest that may arise as a result of an outside relationship or personal
interest of a member of the Technical Panel. Specifically, all panelists are asked to provide
disclosure statements of all relationships that may be perceived as real or potential conflicts of
interest….A table of disclosures of the Technical Panel and Task Force Members can be found in
the Appendix D.” (Appendix D presents a table listing for each committee member any research
grants, speaking support, stock ownership, board of director affiliations, and industrial
consultation relationships.)
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Example of author listing: “Pamela S. Douglas, MD, MACC, FAHA, FASE-Lead Author,
Appropriateness Criteria for Stress Echocardiography-Past President, ACC, Past President, ASE,
Ursula Geller Professor of Research in Cardiovascular Diseases, Duke University Medical
Center, Durham, NC.”
14.

Evidence strengths, limitations.
“Care was taken in providing objective, nonbiased information, including guidelines and

key references, to the Technical Panel.”
15.

Method for formulating recommendations.
“To prevent bias in the scoring process, the Technical Panel deliberately was not

comprised solely of specialists in the particular procedure under evaluation. Specialists, while
offering important clinical and technical insights, might have a natural tendency to rate the
indications within their specialty as more appropriate than nonspecialists. In addition, care was
taken in providing objective, nonbiased information, including guidelines and key references, to
the Technical Panel.”
“Two rounds of ratings with lively discussion between the ratings did lead to some
consensus among panelists. However, further attempts to drive consensus would have diluted
true differences in opinion among panelists and, therefore, was not undertaken.”
Comment: Specific areas of disagreement are noted in the discussion of results of ratings.
16.

Link between evidence & recommendations.
“The indications were constructed by echocardiography experts and modified on the

basis of discussions among the Task Force and feedback from independent reviewers and the
Technical Panel Whenever possible, indications were mapped to relevant clinical guidelines and
key publications/references.”
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Guideline 5: American Institute of Ultrasound in Medicine
Practice Guideline for the Performance of the Musculoskeletal Ultrasound Examination (2007)
(Analysis: Table 7)
The first of two AIUM guidelines I reviewed is the Practice Guideline for the
Performance of the Musculoskeletal Ultrasound Examination, published in 2007.
This guideline addresses an ultrasound examination that may be performed in traditional
settings by sonographers or physicians, but is commonly performed by physicians as a point-ofcare exam. The thirteen-page guideline developed in collaboration with the American College of
Radiology, includes eight sections. The first, the “Introduction,” describes the collaborative
nature of the guideline and identifies the target users. Standard organization recommendations
are provided in Sections Two, Three, Four, Six, and Eight. Section Seven, “Equipment
Specification,” describes optimal equipment for this exam.
Section Five, “Specifications for Individual Examinations,” comprises the body of the
guideline. In this section, authors recommend examination views and techniques for acquiring
those views. Under appropriate subheadings, instructions are provided for examining each
structure, and for using ultrasound to guide interventional procedures. At the conclusion of the
guideline, the drafters and references are listed. Following in Table 7 I report attribute ratings for
this guideline. (EASY TO READ, etc??
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Table 7: Practice Guideline for the Performance of the Musculoskeletal Ultrasound Examination
(2007)
Guideline Developer: American Institute of Ultrasound in Medicine and the American
College of Radiology
Guideline Category(s)

GC1 ______

GC2 ______ GC3 ___x___

Instructions:
Rate Items 1 – 12 for ALL Guidelines.
4 = Strongly Effective
3 = Moderately Effective
2 = Moderately Ineffective
1 = Strongly Ineffective, or Missing
GC1 and GC2 Guidelines: Rate Items 13 – 16 *
GC3 Guidelines : Rate Items 17 – 20 **
#

ATTRIBUTE
1 Guideline objectives

RATING
4 3 2 1
x

2 Health question(s)

x

3 Target population

x

4 Target users

x

5 Updating procedure

x

6 Recommendations

7 Management options

x

x

COMMENTS
The guideline states a general purpose,
but no specific objectives.
(see comments below)
Health questions are weakly implied
throughout the guideline.
(see comments below)
The target population is indirectly
identified according to indications.
Physicians and sonographers are
mentioned, but users are only identified
by the nonspecific term “practitioner.”
(see comments below)
No plan for updating the document is
provided.
The guideline is highly informative, but
most recommendations are weakly
stated in nondirective language.
(see comments below)
Optional positions are suggested to
accommodate patient’s conditions;
additional views are recommended
when conditions warrant.
(see comments below)
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#

ATTRIBUTE
8 Key recommendations

RATING
x

9 Implementation tools
10 Monitoring, audit criteria,
and suggestions for future
research
11 Competing interests of
CPG development group
12 Logical presentation

x
x
x
x

COMMENTS
Recommendations are embedded
within paragraphs, making them
difficult to identify.
(see comments below)
The document does not incorporate any
implementation tools.
None are provided.
No conflict of interest statement is
provided.
Examination performance steps are
logically ordered.

*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY!
13 Evidence selection criteria
14 Evidence strengths,
limitations
15 Method for formulating
recommendations
16 Link between evidence &
recommendations
**Rate Items 17 – 20 for CG3 guidelines ONLY!
17 Appropriateness criteria
x No criteria are provided.
18 Clearly presented steps
x
Steps are difficult to pick out where
they are embedded in paragraphs, and
most are passively worded.
19 Effective document design
x
The overall document is wellorganized, but it contains long, dense
paragraphs, very little white space, and
no graphics.
20 Expert reference
x
The principal drafter was identified.
This author is a leading expert in
musculoskeletal ultrasound, and
including his professional affiliation
and/or background would enhance the
document’s strength.
8 1 6 5
TOTAL SCORES:
8
= _______37 / 64_______
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COMMENTS
1.

Guideline objectives.
“This guideline has been developed to assist practitioners performing a musculoskeletal

ultrasound examination. While it is not possible to detect every abnormality, adherence to the
following guidelines will maximize the probability of detecting most abnormalities that occur.”
2.

Health question(s).
“The indications for ultrasound include, but are not limited to, evaluation of shoulder

pain or dysfunction.”
“These (previously mentioned) views should be used to determine if the tendon is
properly positioned within the bicipital groove, subluxated, dislocated, or torn.”
4.

Target users.
“This guideline has been developed to assist practitioners performing a musculoskeletal

ultrasound examination.”
“A physician must be available for consultation with the sonographer on a case-by-case
basis. Ideally, the physician should be on-site and available to participate actively in the
ultrasound examination when required.”
18.

Clearly defined steps.
“The palm is placed down on the table, or if the patient is supine, the forearm is placed

across the abdomen, with the elbow flexed to 90o. The posterior joint space, triceps tendon,
olecranon process, and olecranon bursa are assessed.”
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Guideline 6: American Institute of Ultrasound in Medicine
Practice Guideline for the Performance of Fetal Echocardiography (2010) (Analysis: Table 8)
The second AIUM guideline I reviewed is the Practice Guideline for the Performance of
Fetal Echocardiography, published collaboratively with the American College of Obstetricians
and Gynecologists and the Society for Maternal-Fetal Medicine, three years later in 2010.
Although this is the first AIUM guideline dedicated to this topic, the exam has been performed
by sonographers and physicians for several years and fits the criteria of “traditional.”
Many sections of this guideline are similar in purpose to corresponding sections in the
Musculoskeletal Guideline, but there are differences in usability features. In contrast to
Musculoskeletal’s dense text discussion of recommended views, Fetal Echo lists views in
bulleted lists. The Fetal Echo guideline also includes detailed illustrations, referenced in the text.
There are also differences in transparency of links between evidence and recommendations. The
Fetal Echo guideline contains embedded recommendations, a convention that has only been
adopted for AIUM guidelines during the past two years. Also in the Fetal Echo guideline, the
authors characterize the major imaging techniques as “Recommended” or “Optional,” depending
on other patient conditions. The attribute ratings for this guideline follow in Table 8.
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Table 8: Pactice Guideline for the Performance of Fetal Echocardiography (2010)
Guideline Developer: American Institute of Ultrasound in Medicine, American College
of Radiology, American College of Obstetricians and Gynecologists, and the Society for
Maternal-Fetal Medicine. Endorsed by the American College of Radiology.
Guideline Category(s) : GC1 ______

GC2 ______ GC3 __x____

Instructions:
Rate Items 1 – 12 for ALL Guidelines.
4 = Strongly Effective
3 = Moderately Effective
2 = Moderately Ineffective
1 = Strongly Ineffective, or Missing
GC1 and GC2 Guidelines: Rate Items 13 – 16 *
GC3 Guidelines : Rate Items 17 – 20 **
#

ATTRIBUTE
1 Guideline objectives

RATING
4 3 2
x

2 Health question(s)

x

3 Target population

x

4 Target users
5 Updating procedure
6 Recommendations

x

7 Management options

x

8 Key recommendations

x

9 Implementation tools

x

COMMENTS
1

x
x

Objectives are obliquely stated; the
expected outcome of applying the
guideline is stated more directly.
(see comments below)
Conveyed through exam definition and
indications
(see comments below)
The target population is defined as
fetuses between 18 and 22 weeks’
gestational age, or younger.
Target users are not identified.
Not provided.
Recommended sonographic techniques
are boldly identified and characterized
according to strength.
(see comments below)
An alternative scan option is suggested
to manage a difficult scan; for some
fetal conditions, additional exam
components are suggested.
(see comments below)
Scan recommendations are identified
clearly as noted in Item 6..
Guideline illustrations aid
implementation.
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# ATTRIBUTE
10 Monitoring, audit criteria,
and future research
11 Competing interests of
CPG development group
12 Logical presentation

RATING
x
x
x

COMMENTS
None provided.
No conflict of interest statements are
provided.
The guideline is well organized and
easy to follow.

*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY!
13 Evidence selection criteria
14 Evidence strengths,
limitations
15 Method for formulating
recommendations
16 Link between evidence &
recommendations
**Rate Items 17 – 20 for CG3 guidelines ONLY!
17 Appropriateness criteria
x
A criteria for judging appropriateness is
provided indirectly.
(see comments below)
18 Clearly defined steps
x
A “sequential segmental analysis” is
provided and structures to include are
listed.
19 Effective document design x
The document is orderly, makes good
use of white space, and it includes
excellent graphics.
20 Expert reference
x
No information is provided to convey
the expertise of the task force members.
3 6 2 4
6
= ________48/64______
TOTAL SCORES:

COMMENTS
1.

Objectives.
“Accurate prenatal diagnosis offers potential clinical benefit with regard to infant

outcomes, especially in those cases that are likely to require prostaglandin infusion to maintain
patency of the ductus arteriosus.”
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“While it is not possible to detect every abnormality, adherence to the following
guideline will maximize the probability of detecting most cases of clinically significant
congenital heart disease.”
2.

Health questions
“Fetal echocardiography is broadly defined as a detailed sonographic evaluation that is

used to identify and characterize fetal heart anomalies before delivery.”
6.

Recommendations. (Note: The following are guideline headings)
Gray Scale Imaging (Recommended)
Doppler Sonography (Optional but Recommended for Suspected Cardiac Flow

Abnormalities)
M-Mode Echocardiography (Optional but Recommended for Cardiac Rate or Rhythm
Abnormalities.)
Cardiac Biometry (Optional but Can Be Considered in the Presence of Structural
Anomalies)
7.

Management options
“Technical limitations … can make a detailed heart evaluation very difficult because of

acoustic shadowing, especially during the third trimester. It may be necessary to examine the
patient at a different time if the heart is poorly visualized.”
“Doppler Sonography (Optional but Recommended for Suspected Cardiac Flow
Abnormalities)”
“Cardiac Biometry (Optional but Can Be Considered in the Presence of Structural
Anomalies)”
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17.

Appropriateness criteria
“A request for the examination must be originated by a physician or other appropriate

health care provider familiar with the patient’s clinical situation and should be consistent with
relevant legal and local health care facility requirements.”

Summary of Findings
Following is a review of the scores assigned to documents for each attribute.
4) Guideline objectives:
3/6 were rated “4.” In the other three guidelines, objectives are stated obliquely or not at
all. Effective strategies included:


a clear statement of topics and clinical imperative



a description of the diagnostic challenge, and the clinical and legal impacts of the clinical
problem



a description of guideline objectives and expected outcomes

5) “Health questions.”
4/6 were rated “4.” Two received lower scores because questions were not provided or
were only weakly implied. Characteristics of effectively presented questions included:


explicit wording,



bold font,



numbering,



prominent location



links with exam indications and recommended practices.

.
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6) “Target population.”.
4/6 were rated “4.” In each of these guidelines, target populations are explicitly defined.
In the other two guidelines, they are identified by indications but by no other characteristics.
7) “Target users.”
4/6 were rated “4.” These four guidelines identified the clinical groups considered
qualified to perform the exam. In one of these guidelines, groups represented in the development
process were identified; another provided suggestions for use of the guideline. In the two
guidelines rated below “4,” target users are identified using nonspecific terms, or they are not
identified at all.
8) “Updating procedures.”
Only these two guidelines stated a plan or timetable for updating. A third acknowledged
the need for updating, but did not provide a plan or timetable.
9) “Recommendations.”
5/6 were rated “4.” The 6th guideline is highly informative, but conveys most
recommendations in weak, nondirective language. Characteristics of effective presentation
included:


unambiguous, directive language



strength grading



justification for each recommendation

10) “Management Options.”
6/6 were rated “4.” All six guidelines recommended optional approaches as warranted.
11) “Key recommendations.”
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4/6 were rated “4.” In the other two, the recommendations are not clearly identified as
key answers to clinical questions, or the recommendations are embedded within paragraphs,
making them difficult to identify. Characteristics of effective approaches included:


responsiveness to specific health questions



ease of identification under informative bolded heading



presentation in tables

.
12) “Implementation tools.”
2/6 were rated “4.” The other guidelines fail to include or make reference to any
implementation tools. Effective techniques included:


recommendations in well-formatted tables



illustrations

13) “Monitoring, audit criteria, and future research.”
2/6 were rated “4.” Those two guidelines suggested areas where future research is needed.
14) “Competing interests of CPG development group.”
2/6 were rated “4.” Disclosure strategies included:


a bolded conflict of interest statement



a strong, specific statement addressing potential relationships between CPG developers
and industrial interests



listing of each author’s professional affiliation and role in the CPG development process.

15) “Logical presentation.”
6/6 were rated “4.”
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Only three of the six guidelines were evaluated for the following attributes:
16) “Evidence selection criteria”
3/3 were rated “4.” In each, the details of the search and selection process are provided.
17) “Evidence strengths, limitations”
2/3 were rated “4.” In the third guideline, the evidence was qualitatively described as
“relevant,” “objective,” and “nonbiased,” but no formal evidence-grading system is provided.
Effective presentation strategies included:


description of the method used to interpret evidence and reduce bias



review of evidence both as a narrative to answer each question, and in evidentiary tables

18) “Method for formulating recommendations”
3/3 were rated “4.” In each, the method was explicitly described. One of the three drew
strongly on judgment and expert opinion for its recommendations. The committee’s formal use
of a modified Delphi exercise is reported, and other steps the committee took to reduce the risk
of bias are described.
19) “Link between evidence and recommendations”
3/3 were rated “4.” In two, each clinical question is explicitly answered with review of
the relevant literature, and recommendations are provided as conclusions from the evidence. In
the 3rd guideline, the role of expert consensus as the link is explicitly stated.
20) “Appropriateness criteria.”
0/3 guidelines were rated “4”
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21) “Clearly presented steps.”
1/3 guidelines were rated “4.” This guideline describes a “sequential segmental analysis”
of structures. In the other two guidelines, the steps are clearly stated and concise, but they are
passively worded and grouped in paragraphs, making the beginning of each step difficult to
locate.
22) “Effective document design”
1/3 was rated “4.” This document displays an orderly format, makes good use of white
space, and includes excellent graphics. In the other two documents, instructions are compressed
into long, dense paragraphs, with very little white space and no graphics.
23) “Expert Reference”
1/3 was rated “4.” In this document, the expertise of the clinician guideline development
group is affirmed. Neither of the others attests to the expertise of the drafters.
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CHAPTER FIVE: CONCLUSIONS
In this concluding chapter I examine the guideline analyses described in Chapter Four
and discuss the conclusions I reached regarding the key questions addressed by this thesis:


How should guidelines for emerging ultrasound applications be assessed?



Is it appropriate to develop guidelines for these applications?



If so, how can these guidelines best be constructed for validity and usability?

How should guidelines for emerging ultrasound applications be assessed?
Among the numerous instruments investigated as guideline quality assessment tools, the
AGREE instrument has emerged as the most widely accepted. However, the developers of
AGREE vaguely advise that for “some” guidelines, certain attributes designated by the
instrument as quality components do not apply. As an example, AGREE authors identify
“Management options” as a non-universal attribute. “… guidelines narrow in scope may not
provide the full range of options for the management of the condition ” (??). In such cases, the
authors suggest “having appraisers skip that item in the assessment process or [rate] the item as
“1” (absence of information) and [provide] context about the score” (??).
The purpose of my study was to address these vague exceptions in order to more
appropriately evaluate guidelines for emerging applications. I theorized that the inconsistencies
that limit applicability of AGREE across guidelines could relate to fundamental differences
among guideline purposes – differences that could be defined and incorporated into AGREE as
adjustment factors to make its rating scheme more universal.
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To test my theory, I first considered characteristics that distinguish different types of
guidelines. Beginning with the NGC Guideline Category definitions as a primary sorting tool, I
grouped NGC Categories into three larger groups according to common characteristics, and
considered how the AGREE tool could be adapted to assess different types of guidelines in a
more tailored fashion. In particular, I considered the attributes related to evidence since these are
problematic for emerging users’ guidelines: evidence selection criteria; evidence strengths and
limitations; methods for formulating recommendations; and linking evidence with
recommendations.
I determined that guidelines that present options should, indeed, provide evidence of
validity, and in the case of stratified options, use evidence to substantiate recommendations.
Following that theory, guidelines in both CG1 and CG2 should be assessed according to these
evidence criteria, and their scores on those attributes should correlate with quality.
For ultrasound performance guidelines, particularly for emerging applications where the
science is young and evidence scarce, however, guideline scores on these four AGREE attributes
are likely to suggest poor quality. But I contend that “low” scores on these 4 items do not relate
to the quality of ultrasound performance guidelines at all. I theorize that convoluting “evidencebased” with “high quality” is misleading. Those 4 attributes are meaningful measures for
“evidence-based” guidelines, but they are not natural or proper quality assessment considerations
for performance guidelines.
Following this theory that the four evidence evaluations are irrelevant to guidelines in the
group I designated as CG3, I removed them from the assessment rubric for this group, replacing
them with two, more relevant, validity attributes: expert reference, and appropriateness criteria.
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I further tailored the instrument to assess usability of this particular group of documents.
In contrast to guidelines that provide “if-then” recommendations, performance guidelines offer
multi-step directions, so in addition to the two new validity attributes I added these two items to
assess usability: clearly presented steps, and effective document design.
To test my category-adjusted assessment approach, I evaluated six ultrasound guidelines.
After assigning each guideline to a category, I rated each attribute and noted relevant text
features. This detailed analysis revealed areas of document weakness that undermine the validity
and usability of the guidelines, but it also illuminated writing approaches that strengthen them
and add value. Regarding the category adjustments, I think they improve the rubric, reducing the
instances of non-applicability. One exception is “Management Options.” I retained that attribute
as universal, but for most of the guidelines in the group I analyzed, it was not truly relevant, and
the scores I assigned and the examples I provided for most were arguably inflated. Another item
that needs reconsideration is the attribute of “Logical presentation.” The term is too vague and
lent very little value to the assessments.
My larger conclusion is that, while I believe tailoring assessment based on overall
guideline purpose improves the tool’s sensitivity, its application needs to be refined. CPGs are
complex documents, and most or all of the CPGs I reviewed contain sections that fit more than
one of the guideline categories I identified. Based on my experience with this study, I conclude
that for a truly legitimate analysis, a guideline’s various sections should be analyzed individually.
Global features, like describing an updating procedure or providing an overall guideline
objective, should be addressed in all guidelines as simple, clear statements, but other attributes,
particularly those that relate to evidence, are more qualitative and complex. In contrast to items
like “updating procedure” which is a stand-alone statement, the qualitative attributes themselves

91

relate to statements. As an example, it seems likely that in the near future performance guidelines
will need to build appropriateness justifications. While the performance portion of the guideline
– its body - may not need a strict evidence base, perhaps appropriateness justifications will
require it and should be judged according to the four evidence-related criteria.

Is it appropriate to develop guidelines for these applications?
One opinion is that guidelines should be written only for topics with a certain level of
available evidence. Certainly unfounded recommendations should not be advanced, but this
paper has included examples of strong recommendations made in the absence of high quality
randomized controlled trials. Flu vaccination is one example of a treatment for which waiting to
perform RCTs before writing guidelines would oppose patients’ best interests. In the case of
ultrasound performance guidelines, the justification for proceeding without “evidence” is a little
different, but I believe valid. I contend that as practices emerge and early adopters develop skill
sets and knowledge worthy of being shared by others, the expertise of those individuals is
sufficient support for a guideline. In all cases, however, the critical and incontrovertible caveat is
that the guideline’s foundation needs to be fully and accurately conveyed by the guideline
drafters.

If so, how can these guidelines best be constructed for validity and usability?
The Guidelines International Network of CPG developers, and others, recognize AGREE
II not only as a reliable quality assessment tool, but also as a useful guideline development tool,
Following that precedent, I developed a template for devising guidelines for emerging ultrasound
applications. The template is based on my revision of the AGREE II instrument, with special
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consideration for the validity and usability challenges inherent in developing guidelines for
emerging ultrasound applications.
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Clinical Practice Guideline (CPG)
DEVELOPMENT TEMPLATE

The quality of clinical practice guidelines depends on their validity and usability.
Following the principles described in this template will help guideline drafters promote
those attributes.

Standard Components
Eight standard text components should appear in every CPG. For each of these
components, guideline drafters should meet the following reporting standards:
1) Objectives:
 Clearly state guideline objectives and rationale.
2) Health question(s):
 Explicitly word and prominently display the health question(s) to be addressed.
3) Target population:
 Describe the target population using humanizing language.
4) Target users:
 Specify all potential user groups.
5) Schedule and procedure for updating:
 Report the publisher’s revision schedule and procedure.
6) Implementation:
 Provide implementation tools, or reference any related tools not described in the
document.
7) Monitoring/audit criteria:
 Supply monitoring and audit criteria, and identify areas for future research.
8) Conflicts of interest:
 Disclose the presence or absence of competing interests for all members of the
CPG development group.
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Specialized Validity Attributes
Two validity attributes should appear in most or all CPGs, but their features will vary
according to the purpose of the guideline.
1) Recommendations:
 Describe the guideline collaboration process, disclosing areas of disagreement,
the method used to resolve differences, and the areas where differences remained
unresolved.
For recommendations based on evidence from the literature:
 Outline the evidence selection criteria.
 Detail strengths and limitations of the evidence.
 Provide unambiguous links between evidence and recommendations.
For recommendations based on expert opinion or consensus:
 Identify the principal drafter and other content experts.
 List content experts’ credentials: professional affiliations, experience, and
publication credits.
2) Appropriateness:
 For evidence-based option stratification, appropriateness is intrinsically
established.
 For all others, provide evidence of cost-benefit outcomes for applying the
<recommended procedure> to answer the <health question(s)> for the <target
population> by the <target users>.
Specialized Usability Attributes
Guideline document usability features should suit the guideline’s purpose.
When documenting evidence-supported recommendations:
 Highlight and prominently display the health questions and recommendations.
 Provide intuitively arranged explicit links between clinical questions, relevant
evidence, and recommended practices.
When describing procedures in a quick reference guide:
 List concise, directive steps.
 Begin each step on a new line.
 Group steps under exam task headings.
 Provide illustrations as needed.
When describing procedures in an extended version:
 Add technical tips and explanations of the purpose or goal of each step as
indicated.
Figure 3: CPG Development Template
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APPENDIX A:
ACCREDITATION
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Alfred Abuhamad, Beryl Benaceraf, Paula Woletz, and Bonnie Burke investigated the
impact of an accreditation program on guidelines implementation, randomly selecting study
subjects from among obstetric/gynecology practices accredited through the American Institute of
Ultrasound in Medicine (AIUM) (Abuhamad 2004).
As part of the AIUM accreditation application, practices submit ultrasound case studies
completed by their practitioners. Submitted obstetric and gynecologic studies are reviewed and
scored for completeness according to criteria defined by AIUM Practice Guidelines for the
Performance of Obstetric Ultrasound Examinations and for the Performance of the Ultrasound
Examination of the Female Pelvis. To maintain accreditation, every three years practices must
repeat the study submission process for reaccreditation.
To evaluate whether participating in the AIUM accreditation program affects practice, for
each practice included in this research, scores on reaccreditation case study submissions were
compared to scores assigned on studies submitted at the time of initial accreditation.
Results of this investigation confirmed that participants in the program improved scores
in case studies submitted for reaccreditation. The authors propose that improved scores imply
greater compliance with practice guidelines, “which should translate into enhancement of the
quality of ultrasound practice.” These findings lend support to my premise that emerging users
will benefit their patients by developing practice guidelines for their new applications
(Abuhamad 2004).
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APPENDIX B:
CPG QUALITY ASSESSMENT AND CONSTRUCTION TOOLKIT

98

The quality of clinical practice guidelines depends on their validity and usability. Following the
principles described in this template will help guideline drafters promote those attributes.

Clinical Practice Guideline (CPG) ASSESSMENT TEMPLATE
Guideline Title:
Guideline Developer:
Guideline Category(s): GC1 ___________ GC2 ____________ GC3___________
Instructions:
Rate Items 1 – 12 for ALL Guidelines.
1 = Strongly Effective
2 = Moderately Effective
3 = Moderately Ineffective
4 = Strongly Ineffective, or Missing
GC1 and GC2 Guidelines: Rate Items 13 – 16 *
GC3 Guidelines : Rate Items 17 – 20 **

#

ATTRIBUTE

1
2
3
4
5
6
7
8
9
10
11
12

Guideline objectives
Health question(s)
Target population
Target users
Updating procedure
Recommendations
Management options
Key recommendations
Implementation tools
Monitoring, audit criteria, and future research
Competing interests of CPG development group
Logical presentation

13
14
15
16

Evidence selection criteria
Evidence strengths, limitations
Method for formulating recommendations
Link between evidence & recommendations

17
18
19
20

Appropriateness criteria
Clearly defined steps
Effective document design
Expert reference

RATING
1 2 3 4

COMMENTS

*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY!

**Rate Items 17 – 20 for CG3 guidelines ONLY!

= ______________

TOTAL SCORES:
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Clinical Practice Guideline (CPG) CONSTRUCTION TEMPLATE

Standard Components
Eight standard text components should appear in every CPG. Following these reporting
standards will enhance guideline quality:
1) Objectives:
 Clearly state guideline objectives and rationale.
2) Health question(s):
 Explicitly word and prominently display the health question(s) to be addressed.
3) Target population:
 Describe the target population using humanizing language.
4) Target users:
 Specify all potential user groups.
5) Schedule and procedure for updating:
 Report the publisher’s revision schedule and procedure.
6) Implementation:
 Provide implementation tools, or reference any related tools not described in the
document.
7) Monitoring/audit criteria:
 Supply monitoring and audit criteria, and identify areas for future research.
8) Conflicts of interest:
 Disclose the presence or absence of competing interests for all members of the
CPG development group.

Specialized Validity Attributes
Two validity attributes should appear in most or all CPGs, but their features will vary
according to the purpose of the guideline.
1) Recommendations:
 Describe the guideline collaboration process, disclosing areas of disagreement,
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the method used to resolve differences, and the areas where differences remained
unresolved.
For recommendations based on evidence from the literature:
 Outline the evidence selection criteria.
 Detail strengths and limitations of the evidence.
 Provide unambiguous links between evidence and recommendations.
For recommendations based on expert opinion or consensus:
 Identify the principal drafter and other content experts.
 List content experts’ credentials: professional affiliations, experience, and
publication credits.
2) Appropriateness:
 For evidence-based option stratification, appropriateness is intrinsically
established.
For all others, provide evidence of cost-benefit outcomes for applying the
<recommended procedure> to answer the <health question(s)> for the <target
population> by the <target users>.

Specialized Usability Attributes
Guideline document usability features should suit the guideline’s purpose.
When documenting evidence-supported recommendations:
 Highlight and prominently display the health questions and recommendations.
 Provide intuitively arranged explicit links between clinical questions, relevant
evidence, and recommended practices.
When describing procedures in a quick reference guide:
 List concise, directive steps.
 Begin each step on a new line.
 Group steps under exam task headings.
 Provide illustrations as needed.
When describing procedures in an extended version:
 Add technical tips and explanations of the purpose or goal of each step as
indicated.
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